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Executive Summary 
Approximately 700 women across the United States (U.S.) die each year as a result of pregnancy or 
pregnancy-related complications. Non-Hispanic black women experience maternal deaths at a rate three 
to four times that of non-Hispanic white women, a racial disparity that is mirrored across many maternal 
and infant outcomes. While surveillance using vital statistics can tell us about trends and disparities, state 
and local maternal mortality review committees (MMRC) are best positioned to comprehensively assess 
maternal deaths and identify opportunities for prevention. The Maternal Mortality Review Information 
Application (MMRIA) and its precursor, the Maternal Mortality Review Data System (MMRDS), assist 
MMRCs in abstracting relevant data from a diversity of sources, documenting committee decisions for each 
reviewed maternal death, and analyzing data for action. Using data from nine MMRCs (hereafter, the Nine 
Committees), this updated and expanded report includes—for the first time—recommendations for 
prevention, discussion of severe maternal morbidity review, and novel work on a MMRIA socio-spatial 
dashboard to incorporate health equity into MMRC discussions.  
Nearly 50% of all pregnancy-related deaths were caused by hemorrhage, cardiovascular and coronary 
conditions, cardiomyopathy, or infection. The leading underlying causes of death varied by race. 
Preeclampsia and eclampsia, and embolism were leading underlying causes of death among non-Hispanic 
black women. Over a three-year period, the United Kingdom had only two deaths from preeclampsia and 
eclampsia, suggesting deaths from these hypertensive disorders of pregnancy are highly preventable. 
Mental health conditions were a leading underlying cause of death among non-Hispanic white women, 
reinforcing the value of MMRCs including mental health-related maternal deaths in the scope of their review, 
and having access to information beyond death certificates.   
The Nine Committees estimated that over 60% of pregnancy-related deaths were preventable. The most 
common factors identified as contributing to the death were patient/family factors (e.g., lack of knowledge 
on warning signs and need to seek care) followed by provider (e.g., misdiagnosis and ineffective 
treatments) and systems of care factors (e.g., lack of coordination between providers). While the Nine 
Committees most commonly identified patient factors, the patient factors identified are often dependent on 
providers and systems of care. For the first time, the Nine Committees provided analyzable 
recommendations to prevent future maternal deaths and the estimated level of potential impact if those 
recommendations were implemented. The following were the most common recommendation themes that 
the Nine Committees also estimated to have the largest potential for population-level impact if implemented: 
adopting levels of maternal care, improving policies regarding prevention initiatives, enforcing policies and 
procedures related to obstetric hemorrhage, and improving policies related to patient management. Social 
and environmental factors may also contribute to a woman’s risk of dying during or within one year of 
pregnancy. MMRCs can incorporate contextual social determinants of health into case discussions, and 
translate findings into specific recommendations. This report is a demonstration of MMRCs’ potential to 
address health equity as a strategy to reduce maternal mortality and severe maternal morbidity. 
To turn the tide on maternal mortality in the U.S. we must build on current momentum and support the 
critical work of MMRCs. State- and local-level MMRCs can be the gold standard for understanding why 
preventable maternal deaths continue to occur and to prioritize ways to effectively reduce maternal deaths. 
As more MMRCs are able to share data, there will be greater understanding and specificity of potential high 
impact recommendations. These recommendations for action will be beneficial for public health and clinical 
care decision-makers as they design strategies to eliminate preventable maternal deaths at the local, state, 
regional and national levels. Describing recommendations for each of the leading causes of death is an 
important step forward; determining the potential of a recommendation to prevent maternal deaths remains 
an important opportunity for the future.   
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Preface 
The data used in this report are made possible by a partnership with nine states that have been supporting 
the development of the Maternal Mortality Review Data System (MMRDS) and/or the Maternal Mortality 
Review Information Application (MMRIA): Colorado, Delaware, Georgia, Hawaii, Illinois, North Carolina, 
Ohio, South Carolina, and Utah. While this report reflects data from the nine states, MMRIA is a reflection 
of lessons learned from implementing MMRDS or MMRIA in a total of 20 state and local MMRCs. The long-
term engagement with these MMRCs has benefited us all through rich mutual learning. Through the 
development of this report, we have come to understand the mechanics of combining and using data from 
multiple MMRCs. We have also identified opportunities for improvement and future possibilities as more 
MMRCs collaborate. 
As of January 1, 2018, the Building U.S. Capacity to Review and Prevent Maternal Deaths team (hereafter, 
project team) has responded to 48 jurisdictions (42 states, five cities and one U.S. territory) requesting 
MMRIA and other MMRC support tools. These jurisdictions, representing approximately 92% of U.S. 
maternal deaths, are listed below.   
1. Alabama Dept. of Public Health 
2. Alaska Maternal & Child Death Review 
3. Arizona Dept. of Health Services 
4. Arkansas Dept. of Health 
5. Colorado Dept. of Public Health & Environment 
6. Connecticut Dept. of Public Health 
7. Delaware Child Death Review Commission 
8. District of Columbia Dept. of Health 
9. Florida Dept. of Health 
10. Georgia Maternal Mortality Review 
11. Hawaii Dept. of Health 
12. Illinois Dept. of Public Health 
13. Indiana State Dept. of Health  
14. Iowa Dept. of Public Health 
15. Kansas Dept. of Health & Environment 
16. Kentucky Dept. for Public Health 
17. Los Angeles County Public Health 
18. Louisiana Bureau of Family Health 
19. Maryland Dept. of Health & Mental Hygiene 
20. Massachusetts Dept. of Public Health 
21. Michigan Dept. of Health & Human Services 
22. Minnesota Dept. of Health  
23. Mississippi State Dept. of Health 
24. Missouri Dept. of Health & Senior Services 
25. Montana Dept. of Public Health & Human Services 
26. Nebraska Dept. of Health & Human Services 
27. Nevada Dept. of Health & Human Services 
28. New Hampshire Dept. of Health & Human Services 
29. New Jersey Central Jersey Family Health Coalition 
30. New Mexico Dept.of Health 
31. New York City Dept. of Health & Mental Hygiene 
32. North Carolina Dept. of Health & Human Services 
33. Ohio Dept. of Health  
34. Oklahoma State Dept. of Health  
35. Oregon Health Authority  
36. Pennsylvania Dept. of Health 
37. Philadelphia Dept. of Public Health 
38. Puerto Rico Dept.of Health  
39. San Antonio (TX) Metropolitan Health District  
40. South Carolina Dept. of Health and Environmental Control 
41. Tennessee Dept. of Health 
42. Texas Dept. of State Health Services  
43. Utah Dept. of Health 
44. Virginia Dept. of Health 
45. Washington Dept. of Health 
46. West Virginia Bureau for Public Health 
47. Wisconsin Dept. of Health Services 
48. Wyoming Dept. of Health 
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The project team partnered with eight MMRCs to develop a logic model that outlines the requirements for 
creating a fully functional MMRC (Figure A). MMRIA provides an opportunity for MMRCs to achieve 
process requirements such as collecting data, producing case summaries, and providing reports using 
robust data; the content of MMRIA was developed with these requirements in mind. 
Figure A. Logic Model for Creating a Fully-Functional Maternal Mortality Review Committee 
 
 
Beyond MMRIA, the project team developed resources and provided focused onsite and distance-based 
technical assistance to address specific challenges MMRCs experience. States have unique needs ranging 
from too few cases for annual reporting, to so many cases that it is difficult to find sufficient resources to 
initiate a review. For smaller states, the project team encourages interstate collaborative use of MMRC data 
at the regional level to add power to their analyses and prevention actions; for larger states, the team is 
exploring opportunities for intrastate collaboration by local reviews.   
The tools developed and the technical assistance provided, coupled with refined MMRIA content and 
ongoing efforts to make data consistent, all support the effective and efficient implementation of MMRCs. 
MMRIA provides a shared data framework that empowers MMRC prevention activities. The U.S. can best 
save lives and prevent harm with thoughtful and strategic practices that honor unique contexts and needs 
at the state and local levels, while simultaneously adopting a cohesive approach that leverages all the data 
we collect on maternal deaths. MMRIA also provides support to reviews that take on emerging issues—
such as maternal suicide, drug overdose, and intimate partner violence—in the form of scientific- and 
practice-based resources and tools. This report is a recognition of our common commitment to eliminating 
preventable maternal deaths and reducing disparities. We can only fulfill our commitment by working 
together. 
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Introduction To Maternal Mortality Review 
Committees 
There are two national sources for trends and information on maternal deaths using vital statistics data 
(Table 1). The first, the National Center for Health Statistics (NCHS), uses death certificate information to 
assign ICD-10 codes that are used to identify maternal deaths and produce a maternal mortality rate (i.e., 
maternal deaths while pregnant or within 42 days postpartum per 100,000 live births). The second, the 
Pregnancy Mortality Surveillance System (PMSS), uses death certificates that show a relationship to 
pregnancy identified by either a checkbox on the death certificate or by a linked birth or fetal death certificate 
registered in the year preceding death. Medical epidemiologists review this information to identify 
pregnancy-related deaths and produce a pregnancy-related mortality ratio (i.e., pregnancy-related deaths 
while pregnant or within a year postpartum per 100,000 live births). 
A reliance on vital statistics alone to measure maternal mortality makes it challenging to determine whether 
changes observed are the result of improved identification of maternal deaths or changes in the risk.[1, 2] 
While surveillance using vital statistics can tell us about trends and disparities, state- and local-based 
MMRCs are best positioned to comprehensively assess maternal deaths and identify opportunities for 
prevention.[3, 4] 
Table 1. National Sources of Maternal Mortality Information* 
 
 CDC – National Center for Health Statistics CDC – Pregnancy Mortality Surveillance System (PMSS)† 
DATA SOURCE DEATH CERTIFICATES 
DEATH CERTIFICATES LINKED TO FETAL DEATH AND 
BIRTH CERTIFICATES 
Time Frame During pregnancy – 42 days postpartum During pregnancy – 365 days postpartum 
Source of 
classification 
International Classification of Diseases, 10th revision 
(ICD-10) codes 
Medical epidemiologists assign PMSS codes 
Terms Maternal death • Pregnancy-associated death, 
• (Associated and) Pregnancy-related death, 
• Associated but not pregnancy-related death 
Measure Maternal mortality rate:   Pregnancy-related mortality ratio: 
# of maternal deaths # of pregnancy-related deaths 
per 100,000 live births per 100,000 live births 
Purpose Show national trends and provide a basis for 
international comparison 
Analyze clinical factors associated with deaths, publish 
information that may lead to prevention strategies 
Strengths • Best source of historical data (back to 1900) Most clinically relevant national measure of the burden of 
maternal deaths 
• Reliable basis for international comparison 
• Based on readily available data (death certificates) 
Challenges • Constrained by ICD-10 codes • Constrained by information available on death and birth 
certificates 
• Lacks sufficient detail to inform prevention 
strategies 
• Lacks detailed information on contributors to deaths 
                                                          
* Adapted from St. Pierre et al, 2017. 5 
†https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pmss.html   
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The foundation for case identification by most MMRCs is linking death certificates to birth certificates or 
fetal death records, an approach that is consistent with PMSS. However, MMRCs have access to additional 
information on maternal deaths, such as medical and social records, that allow a deeper examination of the 
processes and factors leading to the death than what is possible from vital registration information alone. 
Beyond assessing preventability, MMRCs make recommendations, promote, and increasingly implement, 
effective population-based prevention activities. 
Members of MMRCs typically represent public health, obstetrics and gynecology, maternal-fetal medicine, 
nursing, midwifery, forensic pathology, mental health, and behavioral health. Members might also include 
social workers, patient advocates, and other relevant, multidisciplinary stakeholders. Through a partnership 
between the MMRC, the state vital records office, and epidemiologists, deaths among women of 
reproductive age are examined to determine if they occurred during pregnancy or within a year of the end 
of pregnancy (pregnancy-associated deaths). Through this process, potential cases of pregnancy-related 
deaths are then identified.  
Death certificates may indicate a pregnancy-associated death through a pregnancy checkbox or a cause 
of death code related to pregnancy. By themselves, however, death certificates are not sufficient to 
comprehensively identify all pregnancy-associated deaths. To further identify pregnancy-associated 
deaths, a routine linkage should be conducted between all death certificates of reproductive-aged women 
with infant birth or fetal death records for the year preceding death. When pregnancy-associated deaths 
are identified from death certificates alone, a representative of vital records or the MMRC may need to 
confirm that the death occurred during pregnancy or within one year of the end of pregnancy. 
Some MMRCs have additional protocols for identifying pregnancy-associated deaths, such as linkages to 
hospital discharge data, direct hospital reporting, media reports, or obituary searches. All identified cases 
are sent to a MMRC representative to be entered into a database. Sources of case information may include 
birth and death certificate data, prenatal care records, hospital records, autopsy reports, informant 
interview, and social services records. Abstractors distill relevant information from these sources and 
develop committee review materials, including a case narrative, for each case. MMRCs then convene to 
discuss the cases.  
There are six key decisions MMRCs make for each death reviewed: 
1. Was the death pregnancy-related? 
2. What was the underlying cause of death? 
3. Was the death preventable? 
4. What were the factors that contributed to the death? 
5. What are the recommendations and actions that address those contributing factors? 
6. What is the anticipated impact of those actions if implemented? 
While all six questions are essential, the last four questions highlight the unique and critical role of MMRCs: 
preventability, contributing factors, recommendations for improvement, and measurement of potential for 
impact. The analyses included in this 2018 report cover all six questions, two of which overlap with PMSS, 
and four of which are unique to MMRCs. 
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The Data 
Structure 
Nine state-based MMRCs—Colorado, Delaware, Georgia, Hawaii, Illinois, North Carolina, Ohio, South 
Carolina, and Utah—contributed data to this report. These states have been entering data into either 
MMRIA (released in 2017) or its precursor, MMRDS. MMRIA is a custom application and MMRDS is a 
database built on the Centers for Disease Control and Prevention’s (CDC’s) publicly available Epi Info™ 
software version 7.1.5.2. There are 11 forms in MMRDS and 12 forms in MMRIA. For each maternal death, 
there is one form for abstracting information from the death certificate, autopsy report, birth certificate 
(parent section), prenatal care record, social and environmental profile, mental health profile (MMRIA only), 
case narrative (MMRIA only), and ultimately the committee decisions. There may be more than one of the 
following forms completed for a given maternal death: birth certificate (infant or fetal death section), 
emergency room visits and hospitalizations, other medical office visits, medical transports (MMRIA only), 
and informant interviews. We anticipate all states that used MMRDS in 2017 will transition to MMRIA in 
2018. 
Within many of the forms, there are one or more grids for data entry that may be used to store a list of 
relevant information, such as vital signs or laboratory tests. For example, within the autopsy report form, 
there are four grids: gross findings, microscopic findings, causes of death, and toxicology. Grids contain 
multiple data fields that relate to a common event or finding. For example, the toxicology grid from the 
autopsy report contains fields for substance, concentration, unit of measure and comments.  
Years 
Years of deaths included in these analyses vary between the Nine Committees.  
Colorado 2008—2012 
Delaware 2009—2015 
Georgia 2012—2014 
Hawaii 2015 
Illinois 2015 
North Carolina 2014—2015 
Ohio 2008—2015 
South Carolina 2014—2017  
Utah 2014 
Rather than report trends in pregnancy-related mortality over time, our overarching focus in this report is to 
demonstrate the use of standardized MMRC data for understanding preventability, factors that contribute 
to deaths, and best opportunities for reducing pregnancy-related deaths; thus, the variation in years 
between states is not a barrier to the collective use of these data. As more MMRCs use MMRIA and are 
able to share data, it may be possible to look at both the most current and the overall data. 
Race and ethnicity 
Where possible throughout the report, we present findings by race-ethnicity, age, and timing of death. While 
race and ethnicity are captured in the data set just as they are recorded on the source documents, and 
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recoded consistent with Office of Management and Budget Race and Ethnic Standards for Federal 
Statistics and Administrative Reporting[6], available data did not support analysis beyond non-Hispanic 
white, non-Hispanic black and Hispanic groupings. In the future, with more MMRCs contributing data, we 
may be able to describe deaths by additional race and ethnicity categories. We used race and ethnicity 
data from the birth certificate when available and from death certificates when a birth certificate was 
unavailable, based on evidence that the birth certificate is a more reliable source of data on race and 
ethnicity.[7]  
Age at death 
Using information from death certificates, age at death is captured as a continuous variable in the data set. 
For the purposes of analysis, we grouped age at death into six categories: 
 Younger than 20 years 
 20-24 years 
 25-29 years 
 30-34 years  
 35-44 years 
 45 years and older  
Timing of death in relation to pregnancy 
The timing of a woman’s death in relation to pregnancy is captured in two ways. Death certificates capture 
the relationship of death to pregnancy through a pregnancy checkbox. Standard checkbox options, as 
specified by the National Center for Health Statistics, are: 
If female:  
 Not pregnant within past year 
 Pregnant at time of death 
 Not pregnant, but pregnant within 42 days of death 
 Not pregnant, but pregnant 43 days to 1 year before death 
 Unknown if pregnant within the past year 
 
In addition, when a death certificate links to a birth or fetal death record, then the number of days between 
death and the end of pregnancy is calculated within MMRDS/MMRIA. We grouped this continuous variable 
into categories consistent with the death certificate checkbox options. When this information was missing 
or unknown, we used timing information on the death certificate checkbox.   
Data cleaning 
Data from the Nine Committees were cleaned to ensure that only valid observations remained for analysis. 
In addition, four duplicate entries were identified and removed.  
We present the following analyses of the Nine Committee data in six sections, corresponding to each of the 
six key decisions that MMRCs make. Within each section, the project team provides background and 
definitions, a description of the results of the Nine Committee analyses specific to that question, and a 
discussion of how we are moving forward to better understand opportunities for preventing pregnancy-
related deaths.   
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Question 1: Was the Death Pregnancy-Related? 
Background and definit ions 
The first decision a committee makes is whether a death was pregnancy-related. 
Pregnancy-associated deaths include all deaths that have a temporal relationship to pregnancy but not 
necessarily a causal relationship to pregnancy. Within the universe of pregnancy-associated deaths are 
pregnancy-related deaths. Pregnancy-related deaths refer to the death of a pregnant or postpartum woman 
as a result of her pregnancy. MMRCs start ascertaining pregnancy-related deaths by casting the widest net 
possible, identifying all deaths among women with any evidence of pregnancy in the year before death (i.e. 
pregnancy-associated deaths). A subset of these may be determined to be pregnancy-related deaths — 
deaths causally related to pregnancy or its management that occur during pregnancy or within a year of the 
end of a pregnancy (i.e., abortion, live birth, fetal or infant death).  
MMRCs document their decision on pregnancy-relatedness using the following four categories: 
 Pregnancy-related: The death of a woman during pregnancy or within one year of the end of 
pregnancy from a pregnancy complication, a chain of events initiated by pregnancy, or the 
aggravation of an unrelated condition by the physiologic effects of pregnancy. 
 Pregnancy-associated, but NOT related: The death of a woman during pregnancy or within one 
year of the end of pregnancy from a cause that is not related to pregnancy. 
 Unable to determine if pregnancy-related or pregnancy-associated, but NOT related 
 Not pregnancy-related or associated (i.e., false positive, woman was not pregnant within one year 
of her death) 
Results 
Data from the Nine Committees include a total of 855 potential pregnancy-related deaths. Among these, 
119 were determined to have no evidence of pregnancy within the year prior to the woman’s death (not 
pregnancy-related or -associated; false positive pregnancy-associated deaths); therefore, they were 
excluded from further analyses. Information on pregnancy-relatedness was missing for 23 deaths and the 
Nine Committees determined an additional 33 deaths were pregnancy-associated but were unable to 
determine the pregnancy-relatedness; these 56 deaths were excluded from further analyses. 
Among the 680 valid pregnancy-associated 
deaths for which relatedness could be determined, 
the Nine Committees determined 237 were 
pregnancy-related (34.9%). Pregnancy-related 
deaths occurred more commonly within 42 days of 
the end of pregnancy (45.0%) than during 
pregnancy (37.6%) or 43 days to one year after 
the end of pregnancy (17.5%) (Figure 1).  
Variations in race-ethnicity (Figure 2) and age 
(Figure 3) were observed in the proportion of 
pregnancy-associated deaths determined to be 
pregnancy-related. 
Figure 1. Distribution of Pregnancy-Related Deaths by Timing of 
Death in Relation to Pregnancy  
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Figure 2. Proportion of Pregnancy-Associated Deaths Determined to be Pregnancy-Related, by Race-Ethnicity 
 
Figure 3. Proportion of Pregnancy-Associated Deaths Determined to be Pregnancy-Related, by Age at Death 
 
Moving forward 
Information about pregnancy-related deaths. Data from the Nine Committees show variation in the 
proportion of pregnancy-associated deaths that are pregnancy-related by race-ethnicity and age at death. 
As more MMRCs are able to incorporate their data, we can illustrate and compare this variation within and 
across various categories, including race-ethnicity, age at death, and geography.  
Consistency of pregnancy-related death decisions. The project team continues to provide technical 
assistance—in-person and distance-based—to support consistent decision making within and across 
MMRCs. As more MMRCs are able to share their data, we will be able to look for inconsistencies in 
decisions about pregnancy-relatedness to improve or develop support tools.  
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Question 2: What Was the Cause of Death? 
Background and definit ions 
The causes of death can be captured two ways in the data set. The first way allows MMRCs to document 
causes of death, using free text fields, consistent with how the certifier of a death certificate documents 
causes of death: immediate, underlying, and contributing causes. This approach works well for capturing 
all causes of death, but free text fields do not work well for documenting causes of maternal death in a 
standard way across MMRCs. To encourage standardization and consistency in documenting the cause of 
death, the second approach for documenting MMRC decisions on causes of death is consistent with how 
the underlying cause of death is coded by the CDC Pregnancy Mortality Surveillance System (PMSS).† The 
PMSS codes were developed by CDC and the American College of Obstetricians and Gynecologists 
(ACOG) Maternal Mortality Study Group as a standard approach for classifying pregnancy-related deaths 
in clinically meaningful ways.[8, 9] The consistency provided by the PMSS maternal mortality cause of death 
list, or PMSS-MM codes, overcomes a significant hurdle that limited data sharing by MMRCs in the past 
(refer to Appendix A for PMSS-MM codes). 
Results 
Of the 237 pregnancy-related deaths, 215 (90.7%) had a PMSS-MM underlying cause of death code 
assigned by the committee. For three (1.4%) of the 215, the PMSS-MM code indicated the committee could 
not determine an underlying cause of death. From the 74 potential underlying causes of death included in 
the PMSS-MM codes, the Nine Committees used a total of 52 codes for the 215 deaths. To support 
analyses using the underlying cause of death, a condensed set of 22 causes of death was created, as 
described in Appendix B. 
Overall, there were seven leading underlying causes of pregnancy-related death, accounting for 72.1% of 
all pregnancy-related deaths (Figure 4). In addition, there were at least 5 pregnancy-related deaths due to 
each of the following: amniotic fluid embolism (4.2%), homicide (3.3%), cerebrovascular accidents (2.8%), 
unintentional injury (2.8%), anesthesia complications (2.3%), and autoimmunie diseases (2.3%). 
 
Figure 4. Leading Underlying Causes of Pregnancy-Related Deaths* 
                                                          
* Amniotic fluid embolism is not included in the embolism grouping due to differences in etiology and opportunities for prevention. 
† The underlying cause of death, as defined by the World Health Organization (WHO), is “disease or injury that initiated the train of events leading directly to death, 
or the circumstances of the accident or violence which produced the fatal injury.” 
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State variations. The leading underlying causes of death varied among states. Only two states had the 
same three leading causes of pregnancy-related deaths (cardiovascular and coronary conditions, 
hemorrhage, and infection); however, states with small numbers of pregnancy-related deaths made it 
difficult to draw comparisons across all states. 
Race-ethnicity variations. The leading underlying causes of death varied between non-Hispanic white and 
non-Hispanic black pregnancy-related deaths (Figure 5). Among non-Hispanic white pregnancy-related 
deaths, the leading underlying causes of death were comprised of five causes: 
1. Cardiovascular and coronary conditions (at 15.5%), 
2. Hemorrhage (at 14.4%), 
3. Infection (at 13.4%), 
4. Mental health conditions (at 11.3%), and 
5. Cardiomyopathy (at 10.3%).  
These top five causes represent 64.9% of non-Hispanic white pregnancy-related deaths.  
Among non-Hispanic black pregnancy-related deaths, the following were the five leading underlying 
causes: 
1. Cardiomyopathy (at 14.0%), 
2. Cardiovascular and coronary conditions (at 12.8%), 
3. Preeclampsia and eclampsia (at 11.6%), 
4. Hemorrhage (at 10.5%), and  
5. Embolism (at 9.3%). 
 
These causes represent just 58.1% of non-Hispanic black pregnancy-related deaths, suggesting a broader 
diversity of pregnancy-related causes of death among non-Hispanic black women than among non-
Hispanic white women.  
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Figure 5. Leading Underlying Causes of Pregnancy-Related Deaths, by Race-Ethnicity 
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There were not sufficient data to examine the leading underlying causes of pregnancy-related deaths 
among Hispanic women.  
Age variations. The leading underlying causes of pregnancy-related death varied by age at death (Figure 
6). 
Among women ages 20-24 years, there were six leading underlying causes of pregnancy-related death: 
 Cardiomyopathy and infection (both at 12.8%), 
 Cardiovascular and coronary conditions, preeclampsia and eclampsia (both at 10.6%), and 
 Hemorrhage and mental health conditions (both at 8.6%). 
These causes represent 63.8% of pregnancy-related deaths in this age group.  
Among women ages 25-29 years, there were five leading underlying causes of pregnancy-related death: 
 Cardiovascular and coronary conditions, hemorrhage, and embolism (both at 12.5%), and 
 Cardiomyopathy and mental health conditions (both at 10.0%). 
These causes represent 57.5% of pregnancy-related deaths in this age group.  
Among women ages 30-34 years, there were five leading underlying causes of pregnancy-related death: 
 Infection (15.3%), 
 Hemorrhage and cardiovascular and coronary conditions (both at 13.6%), and  
 Cardiomyopathy and embolism (both at 10%). 
These causes represent 62.7% of pregnancy-related deaths in this age group.   
Among women ages 35-44 years, there were five leading underlying causes of pregnancy-related death: 
 Cardiovascular and coronary conditions (17.8%), 
 Hemorrhage, preeclampsia and eclampsia (both at 15.6%), and 
 Cardiomyopathy and embolism (both at 8.9%). 
These causes represent 66.7% of pregnancy-related deaths in this age group. 
Cardiomyopathy, cardiovascular and coronary conditions, and hemorrhage are leading causes of 
pregnancy-related death that occurred among all age groups (Figure 6). 
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Figure 6. Leading Underlying Causes of Pregnancy-Related Deaths, by Age at Death (in Years) 
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Timing of death variations. The leading underlying causes of pregnancy-related death varied in timing of 
death (Figure 7).   
Among pregnancy-related deaths that occurred during pregnancy, hemorrhage and cardiovascular and 
coronary conditions (both at 19.7%) were the leading causes of death, followed by embolism (9.2%).  
Among hemorrhage deaths, three (12.5%) were due to ectopic pregnancy and 6 (25%) were due to 
abnormal placental implantation. Together, these three causes represented 48.7% of pregnancy-related 
deaths that occurred during pregnancy.    
Among deaths that occurred within 42 days of the end of pregnancy, infection (21.7%) was the leading 
cause of death, followed by hemorrhage (12.4%), cardiovascular and coronary conditions (12.4%), and 
preeclampsia and eclampsia (9.3%). Together, these four causes represented 55.7% of deaths that 
occurred during this time period.   
Among deaths that occurred 43 days to one year after the end of pregnancy, there were three leading 
causes of pregnancy-related death: cardiomyopathy (32.4%), mental health conditions (16.2%), and 
embolism (10.8%). Together, these three causes represented 59.5% of deaths in this time period.  
Moving forward 
Cause of death groupings. A limitation of the cause of death groupings is that they may be masking 
important differences between causes of death within a grouping. As more reviews are able to contribute 
their data to aggregated analyses, we will be increasingly able to disaggregate cause of death groupings 
to identify these differences. Based on feedback from subject matter experts, amniotic fluid embolism has 
been added as a separate cause of death grouping due to differences in etiology and opportunities for 
prevention, and is no longer included with other embolisms. 
Contributors and mechanisms. The project team updated the PMSS-MM codes within MMRIA to help clarify 
cause of death categories. The committee review and decisions form has been modified to document 
important contributors, such as obesity, and mechanisms of death that are not always underlying causes 
of death, such as suicide. Refer to Appendix A for a complete PMSS-MM code listing available to MMRCs 
in MMRIA and to see how contributors and mechanisms are captured. 
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Figure 7. Leading Underlying Causes of Pregnancy-Related Deaths, by Timing of Death in Relation to Pregnancy 
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Question 3: Was the Death Preventable?  
Background and definit ions 
When combined with other committee decisions, there is a critical role for information on preventability. The 
most frequent causes of pregnancy-related death can point to the greatest burdens, but they say little about 
where the potential opportunities for prevention lie. Assessing preventability among the leading causes of 
death permits analysts to consider both the burden and potential opportunity for prevention. Determining 
preventability is one of the unique and critical roles that MMRCs can play in driving actions that will eliminate 
preventable maternal deaths. 
Determining preventability can be challenging and intimidating for MMRCs due to the range of possible 
interpretations of the term. Using input from MMRCs and experts across the country, we developed the 
following definition of preventability: a death is considered preventable if the committee determines that 
there was at least some chance of the death being averted by one or more reasonable changes to patient, 
community, provider, facility, and/or systems factors.[10] MMRIA allows MMRCs to document their decision 
using two approaches: 1) determining preventability as a “yes” or ”no”, and/or 2) determining the chance to 
alter outcomes using a scale that indicates “no chance”, “some chance”, or “good chance” (Appendix A). 
There is value in both ways of documenting preventability, because a ”yes” or “no” does not provide detail 
on the degree of preventability, other than there was at least some chance to alter the outcome. With a 
”yes” or “no”, “some chance” and “good chance” are treated the same. The scale response provides 
additional specificity to the degree of preventability. For the purposes of this analysis, responses to the 
“yes” or “no” and the scale response questions were combined to create one composite preventability 
variable. A “yes” response or a response of “some chance” or “good chance” were coded as “preventable”; 
a “no” response or “no chance” were coded as “not preventable”. 
Results 
The Nine Committees estimated that 63.2% of pregnancy-related deaths were preventable (Figure 8). 
Preventability varied by cause of death, with 68.2% of cardiovascular and coronary deaths and 70.0% of 
hemorrhage deaths estimated to be preventable. 
 
Figure 8. Distribution of Preventability Among Pregnancy-Related Deaths 
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Similarly, variations in the percentage of deaths estimated to be preventable varied by timing of death in 
relation to pregnancy. An estimated 63.2% of deaths that occurred during pregnancy, 66.7% of deaths that 
occurred within 42 days of the end of pregnancy, and 58.3% of deaths that occurred between 43 days and 
one year after the end of pregnancy were determined to be preventable (Figure 9).  
 
Figure 9. Distribution of Preventability Among Pregnancy-Related Deaths, by Timing in Relation to Pregnancy 
 
 
Moving forward  
Documenting preventability. It is encouraging that MMRCs could not determine preventability for only 3% 
of pregnancy-related deaths, suggesting a high potential for complete data when MMRCs include 
preventability in their determinations. Assessing preventability should be a priority because it is critical to 
informing and prioritizing potential actions. Using data from the Nine Committees, our analyses found that 
63% of pregnancy-related deaths were preventable, and the preventability for deaths due to hemorrhage 
was a high of 70%. In comparison, the proportion of pregnancy-related deaths identified as preventable in 
published literature ranges from 20% to 50%.[10-12] In last year’s MMRC report, 59% of pregnancy-related 
deaths were determined preventable based on data from four MMRCs. It is encouraging that the data from 
the Nine Committees found a similar, though slightly higher percentage to be preventable, suggesting a 
possible shift over the last decade toward increased opportunities for prevention. With more complete data, 
we can continue to evaluate preventability by additional leading causes of pregnancy-related deaths.  
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Question 4: What Were the Factors that Contributed to this 
Death? 
Background and definit ions 
After a committee determines that a death is pregnancy-related, identifies the underlying cause of death, 
and determines potential preventability, they proceed to identify the factors that contributed to the death. 
These factors form the basis for a committee’s specific and feasible recommendations. 
MMRIA uses a three-step process to capture information on factors that contribute to a death. First, each 
factor is categorized into one of five levels: patient/family, provider, facility, systems of care, or community. 
Second, each factor is assigned at least one of 23 specific contributing factor classes (along with “other”). 
Contributing factor classes include unstable housing, social support or isolation, violence, and barriers such 
as delays, adherence, and knowledge. Third, the factor is given a concise description by the committee. 
Refer to Appendix A for the complete list of contributing factor classes and definitions. 
Results 
Through the process of case review, MMRCs can identify service delivery and access gaps, as well as 
quality improvement opportunities from each woman’s death. The Nine Committees identified 780 
contributing factors among 195 pregnancy-related deaths (on average, four contributing factors were 
identified for every one pregnancy-related death). 
The largest proportion of factors identified by MMRCs as contributing to pregnancy-related deaths were 
patient/family factors, followed by provider and systems of care factors (Figure 10). Facility and community 
factors were rarely identified. While patient factors were the most common, they were often dependent on 
providers and systems of care, which becomes evident when combined with contributing factor classes and 
descriptions, as shown on pages 29-31.  
Figure 10. Distribution of Contributing Factors among Pregnancy-Related Deaths 
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Leading cause of death variations. Contributing factor classifications vary in their distribution within the 
leading causes of pregnancy-related death (Table 2). Of note is the low ratio of factors per death identified 
for deaths where embolism was the underlying cause (1.6, which is less than one-half of what is observed 
for other causes). This supports earlier findings that embolism deaths are considered one of the least 
preventable among pregnancy-related deaths.[5] 
Table 2. Contributing Factor Level by Leading Causes of Pregnancy-related Death 
 CONTRIBUTING FACTORS 
CAUSE OF DEATH COMMUNITY FACILITY PROVIDER PATIENT 
/ FAMILY 
SYSTEMS 
OF CARE 
TOTAL 
FACTORS 
PREGNANCY 
– RELATED 
DEATHS** 
FACTORS 
PER 
DEATH 
CARDIOVASCULAR & CORONARY CONDITIONS 
Count of Factors 6 12 26 51 25 120 28 4.3 
% of cause-specific 
factors 
5.0 10.0 21.7 42.5 20.8 -- -- -- 
HEMORRHAGE 
Count of Factors 0 7 31 26 36 100 27 3.7 
% of cause-specific 
factors 
-- 7.0 31.0 26.0 36.0 -- -- -- 
INFECTION 
Count of Factors 1 1 36 30 20 88 21 4.2 
% of cause-specific 
factors 
1.1 1.1 40.9 34.1 22.7 -- -- -- 
CARDIOMYOPATHY 
Count of Factors 0 1 24 31 11 67 16 4.2 
% of cause-specific 
factors 
-- 1.7 41.4 43.1 13.8 -- -- -- 
EMBOLISM 
Count of Factors 0 0 5 15 3 23 14 1.6 
% of cause-specific 
factors 
-- -- 21.7 65.2 13.0 -- -- -- 
MENTAL HEALTH CONDITIONS 
Count of Factors 5 3 24 37 19 88 14 6.3 
% of cause-specific 
factors 
5.7 3.4 27.3 42.1 21.6 -- -- -- 
PREECLAMPSIA & ECLAMPSIA 
Count of Factors 2 2 29 13 10 56 11 5.1 
% of cause-specific 
factors 
3.6 3.6 51.8 23.2 17.9 -- -- -- 
Total 14 26 175 203 124 542 131 4.1 
 
**Pregnancy-related deaths that had at least one contributing factor identified. Contributing factors from at least 7 pregnancy-related 
deaths included in the 2017 report are not represented here due to changes in data formatting.
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When contributing factor levels are examined together with the factor class and description, we are able to 
gain a greater understanding of specific contributors among the leading causes of pregnancy-related 
deaths. For each of the leading causes of pregnancy-related death, we provide a summary of the most 
common factor levels, the most common factor classes within the most common factor levels, and the 
dominant themes that emerged from the descriptions.  
Themes from the contributing factor descriptions were coded and reconciled by two coders for the top three 
causes of death. The remaining contributing factors were coded by one coder and reviewed by a second 
coder for consistency. A codebook was developed in tandem with the application of the codes, and changes 
to code names and definitions were discussed and finalized by both coders. Contributing factor themes 
were created by examining the level (e.g., patient/family, provider) and the corresponding class (e.g., 
referral, policies/procedures, continuity of care/care coordination) to develop codes appropriate for each 
level and class combination. In some cases, similar themes were aggregated under a common code even 
if the level/class combinations differed (e.g., “finances” code included both patient and system of care 
contributing factors). Once the contributing factor themes were coded, the data were sorted by theme for 
inclusion in this report. An expanded presentation of this information is included in Appendix C. 
Hemorrhage 
Provider factors comprised 31.0% of the total contributing factors for hemorrhage deaths. The most 
common class of provider factors was assessment, which represented 33.3% of all provider factors. The 
most common themes among provider assessment for both ectopic and non-ectopic hemorrhage were 
delays in diagnosis and effective treatment, missed diagnosis, and ineffective treatments. 
Patient factors comprised 26.0% of the total contributing factors for hemorrhage deaths. The most common 
class of patient factors was knowledge, which represented 30.8% of all patient factors. The most common 
theme among patient knowledge for both ectopic and non-ectopic hemorrhage was patients’ knowledge of 
warning signs and need to seek care. 
Systems of care factors comprised 36.0% of the total contributing factors for hemorrhage deaths. The most 
common class of systems of care factors was personnel at 27.8%, followed by policies and procedures at 
19.4%, and care coordination at 16.7%. Common themes among systems of care personnel, policies and 
procedures, and care coordination were, inadequate training and inadequate or unavailable personnel, 
absence of policies and procedures, and a lack of coordination between providers in patient management. 
Cardiovascular & Coronary Conditions 
Provider factors comprised 21.7% of the total contributing factors for cardiovascular and coronary 
conditions deaths. The most common class of provider factors was knowledge at 16.7%. Common themes 
among provider knowledge were delayed diagnosis and appropriate treatment and ineffective treatments.  
Patient factors comprised 42.5% of the total contributing factors for cardiovascular and coronary conditions 
deaths. The most common class of patient factors was chronic disease and knowledge, which together 
accounted for 41.2% of patient factors. Patient chronic conditions most commonly specified obesity and 
patient knowledge of warning signs and need to seek care.  
Systems of care factors comprised 20.8% of the total contributing factors for cardiovascular and coronary 
conditions deaths. The most common class of systems of care factors was communication. The dominant 
themes identified were lack of communication between providers that supports coordinated care, and 
inadequate or unavailable personnel. 
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Cardiomyopathy 
Provider factors comprised 41.4% of the total contributing factors for cardiomyopathy deaths. The most 
common classes of provider factors were assessment at 33.3% and knowledge and referral both at 16.7%. 
Dominant themes among provider assessment and knowledge included failure to screen, misdiagnosis, 
ineffective treatments, and delayed or missed diagnosis. Failure to seek [cardiology] consultation was a 
common theme among the referral class. 
Patient factors comprised 43.1% of the total contributing factors for cardiomyopathy deaths. The most 
common class of patient factors was chronic disease at 25.8% of patient factors. Common themes among 
patient chronic conditions were obesity and being unaware of warning signs and the need to seek care. 
Systems of care factors comprised 27.3% of the total contributing factors for cardiomyopathy deaths. The 
most common class of system factors was personnel at 27.3%. The most dominant themes among 
personnel were inadequate training and inadequate or unavailable personnel.  
Infection 
Provider factors comprised 40.9% of the total contributing factors for infection deaths. The most common 
class of provider factors was assessment, at 41.7%. A common theme among provider assessment was 
delayed or missed diagnosis, leading to the use of ineffective treatment. 
Patient factors comprised 34.1% of the total contributing factors for infection deaths. The most common 
class of patient factors was chronic disease at 30.0% followed by environmental at 16.7%. Common themes 
among patient chronic conditions were obesity and other contributing diagnoses. A common theme among 
patient environment included housing. 
Systems of care factors comprised 22.7% of the total contributing factors for infection deaths. The most 
common classes of systems of care factors were communication at 20.0% and personnel at 15.0%. The 
dominant themes identified were lack of communication between providers that supports coordinated care, 
and inadequate training, respectively. 
Embolism 
Provider factors comprised 21.7% of the total contributing factors for embolism deaths. The most common 
class of provider factors was provider knowledge at 60.0%. A common theme that emerged was a lack of 
provider knowledge about the use of anticoagulants and thrombolytics.  
Patient factors comprised 65.2% of the total contributing factors for embolism deaths. The most common 
class of patient factors was chronic conditions at 53.3%. The most commonly identified patient chronic 
condition was obesity. 
Mental Health 
Provider factors comprised 27.3% of the total contributing factors for mental health deaths. The most 
common classes of provider factors were provider assessment at 25.0% and provider communication at 
20.1%. The dominant themes that emerged related to provider assessment were failure to screen and the 
use of ineffective treatments. The most common themes for communication were a lack of communication 
between providers to support coordinated care and a lack of communication between providers and 
patients/families.  
Patient factors comprised 42.1% of the total contributing factors for mental health deaths. There was not a 
predominant class of patient factors, with classes split across substance use, social support, knowledge, 
environment, and adherence. Themes that emerged from these classes included lack of adherence to 
medications or treatment plans, abusive relationships and unstable housing, substance use, absence of 
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social support systems, and not recognizing warning signs and the need to seek care. While these factors 
were labeled as patient factors, they are often dependent on providers and systems of care. 
System of care factors comprised 21.6% of the total contributing factors for mental health deaths. The most 
common classes of systems of care factors were communication and continuity of care, both at 22.2%. The 
predominant themes for systems of care communication was a lack of communication between providers 
that supports patient management. Common themes for continuity were inadequate outreach support 
system and inadequate or unavailable personnel. 
Preeclampsia and Eclampsia 
Provider factors comprised 51.8% of the total contributing factors for preeclampsia and eclampsia deaths. 
The two predominant classes were knowledge at 20.7% and referral at 13.8%. Common themes included 
delayed diagnosis or treatment, misdiagnosis, use of ineffective treatments, and failure to seek consultation.   
Patient factors comprised 23.2% of the total contributing factors for preeclampsia and eclampsia deaths. 
The most common class of patient factors was chronic conditions at 30.1%. The most commonly identified 
patient chronic conditions were substance use and obesity. 
While system of care factors comprised only 17.9% of the total contributing factors for preeclampsia and 
eclampsia deaths, 40% were related to communication, and a dominant theme was lack of communication 
as a barrier to coordination of care between providers.  
Moving forward 
Contributing factor descriptions. While at least one contributing factor was identified for more than 80% of 
pregnancy-related deaths, there remains an opportunity for improving the specificity of the open-ended 
descriptions of the contributing factors. Contributing factor descriptions add a richness to the quantitative 
level and class responses. Typical of analytic approaches for open-ended responses, we qualitatively 
assessed the descriptions to identify themes. As we increase the number of MMRCs able to contribute data 
to support a report, we will explore alternative approaches to analyze the open-ended descriptions of 
contributing factors. 
Community-level factors. We will work with MMRCs to understand if the limited amount of community 
factors reflects a genuine absence, or if there are opportunities to improve MMRCs’ abilities to identify 
community-level contributors, such as expanding committee membership. Identifying community-level 
contributors may also benefit from our work to integrate socio-spatial information into case discussions [see 
Incorporating Equity – an Update].  
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Question 5: What Are the Recommendations and Actions That 
Address Those Contributing Factors? 
Background and definit ions 
There is one key question that a review committee can use to help them move to case-specific 
recommendations: If there was at least some chance that the death could have been averted, what were 
the specific and feasible actions, if implemented or altered, that might have changed the course of events? 
Committees should attempt to develop a recommendation for each contributing factor level-class 
combination identified. An effective recommendation addresses who is responsible to act, what the action 
is, and when the action should take place. Concise, feasible, and specific recommendations are the 
culmination of the committee’s discussions and decisions. The importance of this portion of committee 
discussion should not be underestimated. 
For example, if the MMRC determines that a mental health condition was the underlying cause of death, 
that substance use disorder contributed to the death, and that a lack of provider assessment—specifically, 
not screening for substance use disorder during prenatal care—was  a contributing factor, then an 
actionable recommendation could be that prenatal care providers should screen all patients for substance 
use disorders at their first prenatal visit. 
Recommendation themes (e.g., improve training, enforce policies and procedures, ensure appropriate level 
of care determination, etc.) were coded and reconciled by two coders as previously described for the coding 
of contributing factor themes.  
Results 
The Nine Committees identified 193 recommendations among 58 pregnancy-related deaths that were 
coded into themes (on average, three to four recommendations were identified for every one pregnancy-
related death). The most common themes among pregnancy-related deaths included the following: 
 Improve training 
 Enforce policies and procedures 
 Adopt levels of maternal care/ensure appropriate level of care determination*** 
 Improve access to care 
 Improve patient/provider communication 
 Improve patient management for mental health conditions 
 Improve procedures related to communication and coordination between providers 
 Improve standards regarding assessment, diagnosis and treatment decisions 
 Improve policies related to patient management, communication and coordination between 
providers, and language translation 
 Improve policies regarding prevention initiatives, including screening procedures and substance 
use prevention or treatment programs 
An expanded presentation of this information, including specific examples from each recommendation 
theme, is included in Appendix D.  
                                                          
*** For more information on levels of maternal care, refer to the ACOG and SMFM Obstetric Care Consensus Statement: https://www.acog.org/Clinical-Guidance-
and-Publications/Obstetric-Care-Consensus-Series/Levels-of-Maternal-Care 
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Leading cause of death variations. While there is overlap in recommendations by the leading causes of 
death, there is also some variation. Recommendations for the two leading causes of death (cardiovascular 
and coronary conditions and hemorrhage) both include improving training, adopting levels of maternal care, 
improving procedures related to communication and coordination between providers, and improving 
standards and policies (Table 3). However, improving access to care and improving policies specific to 
prevention initiatives were additional recommendation themes for cardiovascular and coronary conditions. 
In contrast, recommendation themes for hemorrhage also included enforcing policies/procedures and 
improving patient/provider communication. Additionally, a recommendation for mandating autopsies was 
noted, which would provide MMRCs with a more thorough account of the clinical causes of death.  
Table 3. Recommendation Themes for Action, by Cause of Death 
CARDIOVASCULAR AND CORONARY CONDITIONS HEMORRHAGE 
Improve training Improve training 
Adopt maternal levels of care/Ensure appropriate level of care 
determination 
Adopt maternal levels of care/Ensure appropriate level of care 
determination 
Improve procedures related to communication and 
coordination between providers  
Improve procedures related to communication and 
coordination between providers 
Improve standards regarding assessment, diagnosis, and 
treatment decisions 
Improve standards regarding assessment, diagnosis, and 
treatment decisions 
Improve policies related to patient management, 
communication and coordination between providers, and 
language translation 
Improve policies related to patient management, 
communication and coordination between providers, and  
language translation  
Improve access to care Improve patient/provider communication 
Improve policies regarding prevention initiatives Enforce policies/procedures 
 Mandate autopsies 
 
Moving forward 
Complete and effective recommendations. Through trainings, site visits, and technical assistance, we will 
continue to work with MMRCs to ensure that they develop effective recommendations and that these are 
documented in MMRIA. The recommendations are critical to understanding what specific actions 
committees identify as the best opportunities for preventing pregnancy-related deaths. This report 
represents an advancement in the ability to present cause of death-specific recommendations. However, a 
specific recommendation was identified for only 24% of pregnancy-related deaths, highlighting the 
opportunities for improving the completeness of recommendations. As more MMRCs are able to share 
data, there will be increased opportunity for identifying specific actions for prevention among all of the 
leading causes of pregnancy-related death. 
Recommendation descriptions. Similar to contributing factors, recommendations are open-ended 
descriptions that require a tailored analytic approach. We will evaluate approaches for analyzing the 
recommendations to identify what is the most appropriate analytic approach. 
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Question 6: What Is the Anticipated Impact of Those Actions If 
Implemented? 
Background and definit ions 
There are two ways that MMRCs capture information in MMRIA related to the potential level of impact their 
recommendations would have if implemented. First, the MMRC assigns a specific level of prevention to 
each recommendation. They determine whether, if implemented, the action would result in what is known 
in public health literature as primary prevention (actions that prevent the contributing factor before it occurs), 
secondary prevention (actions that reduce the impact of a contributing factor once it has occurred), or 
tertiary prevention (actions that reduce the impact or progression of what has become an ongoing 
contributing factor). Recommendations that support primary prevention may be prioritized over those that 
support secondary or tertiary prevention. 
Second, each specific committee recommendation is assigned an expected level of impact if the 
recommendation was implemented, ranging from small to giant. Expected impact levels are adapted from 
the Health Impact Pyramid (Figure 11).[13] The base of the pyramid addresses social determinants of health. 
Actions aimed toward the base of the pyramid have greater potential for population-level impact and require 
less individual effort (referred to as giant). Actions aimed toward the top of the pyramid (referred to as small) 
focus on the individual level (rather than entire populations) and depend on person-by-person behavioral 
change; yet, they require relatively less political will in comparison to the base of the pyramid. Ideally 
MMRCs would identify opportunities across the spectrum of impact levels. 
Figure 11. Expected Level of Impact if Recommendation is Implemented 
 
When MMRCs review deaths, consider preventability, develop recommendations, and assess their likely 
impacts, this information can inform policymakers and other stakeholders in their efforts to prioritize 
recommendations and provide resources to translate them into action for eliminating preventable tragedies. 
Results 
There were 172 responses from the Nine Committees regarding the level of prevention for a 
recommendation, and 169 responses on the level of impact if the recommendation was implemented. Most 
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recommendations were identified as resulting in either primary (36.6%) or secondary (39.5%) prevention, 
and 23.8% of recommendations were identified as resulting in tertiary prevention (Figure 12).  
Figure 12. Level of Prevention for Recommendations 
 
The level of impact if the recommendation was implemented was estimated to be either small or medium 
for 59.7% of recommendations. The level of impact was considered large, extra large or giant for 40.3% of 
recommendations (Figure 13).  
Figure 13. Anticipated Impact of Actions if Implemented 
 
 
In the data from the Nine Committees, we were able to describe how impact levels vary across 
recommendation themes. For example, recommendations for improving training was estimated to have a 
smaller impact, whereas recommendations for improving policies regarding prevention initiatives and 
screening procedures would likely have a larger impact for prevention (Table 4).  
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Table 4. Recommendation Themes for Action and Estimated Potential for Impact if Implemented 
 IMPACT LEVEL (%) 
RECOMMENDATION SMALL TO MEDIUM LARGE TO GIANT 
Improve training 72.7 27.3 
Enforce policies and procedures 40.0 60.0 
Adopt maternal levels of care/Ensure appropriate level of care 
determination 
0.0 100.0 
Improve access to care 50.0 50.0 
Improve patient/provider communication -- -- 
Improve patient management for mental health conditions 80.0 20.0 
Improve procedures related to communication and coordination between 
providers 
55.0 45.0 
Improve standards regarding assessment, diagnosis, and treatment 
decisions 
69.2 30.8 
Improve policies related to patient management, communication and 
coordination between providers, and language translation 
42.9 57.1 
Improve policies regarding prevention initiatives, including screening 
procedures and substance use prevention or treatment programs 
0.0 100.0 
 
The estimated level of impact for recommendations also varies by cause of death (Figure 14). 
Recommendations with large and extra large potential impacts represent more than two-thirds of 
recommendations for the two leading causes of pregnancy-related death. Assessing both the 
recommendations and their level of impact, improving policies regarding prevention initiatives (e.g., 
reimbursement for smoking cessation aids) is the theme that may have the biggest level of impact for 
preventing future deaths due to cardiovascular and coronary conditions. In contrast, enforcing 
policies/procedures and adopting levels of maternal care are themes that may have the biggest impact on 
preventing future deaths due to hemorrhage. 
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Figure 14. Estimated Potential Impact of Recommendations if Implemented, by Cause of Death 
 
Moving forward 
Documentation of impact. Of the six key decisions that a MMRC makes, determining potential impacts may 
be the least familiar. While discussing the impact of recommendations may have been part of stakeholder 
discussions once analyses of maternal death data were complete, documenting the impact of 
recommendations has not historically been a part of each individual case review. Data from the Nine 
Committees demonstrates that over a short period of time, documenting recommendations and their 
impacts for each maternal death has increasingly become a part of committee discussions and decisions. 
In the 2017 report, there were not sufficient data to include analyses related to impact. We will continue to 
work with MMRCs—through trainings, site visits and technical assistance—to document the impact of 
recommendations.  
Recommendations and corresponding impact levels by the leading causes of death were not able to be 
fully presented because recommendations had to be grouped, thus reducing their granularity. As more data 
are collected, reviewing the impact of specific recommendations for each of the leading causes of death 
will provide valuable information for public health decision makers. 
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Data Summary 
Analysis of the data from the Nine Committees demonstrates MMRIA’s ability to help MMRCs better 
understand the drivers of maternal deaths and implement specific, feasible actions to prevent them. MMRIA 
serves as a foundation for bringing maternal death data together and using those data to inform prevention 
activities at local, state, regional, and national levels.  
We used data from the Nine Committees to describe the leading causes of pregnancy-related death. A key 
finding was identifying mental health as a leading underlying cause of pregnancy-related death. This 
supports the value of MMRCs access to information beyond death certificates [see Maternal Mental Health 
– an Update]. We must also acknowledge that these analyses benefited from MMRCs including mental 
health-related maternal deaths in the scope of their review. 
Additionally, analyses of the data from the Nine Committees show that circumstances leading to maternal 
death are complex and multifactorial; no one contributing factor is likely sufficient to result in a death. On 
average, four contributing factors were identified for each pregnancy-related death, suggesting that 
collaborative and multidisciplinary approaches are required to eliminate preventable maternal deaths. Data 
from the Nine Committees identified common contributing factors across leading causes of death. Among 
providers, these factors included lack of assessment—resulting in misdiagnosis—and delayed or ineffective 
treatment. Among patients, factors pointed to complications of obesity and lack of knowledge of warning 
signs, or lack of knowledge of symptoms requiring health care assessment. For systems of care, the key 
factors related to lack of patient care coordination and poor communication between providers. These 
findings highlight potential opportunities for action from multiple stakeholders, including hospitals and public 
health programs. 
Unlike in our previous report, the Nine Committees provided analyzable recommendations to prevent future 
deaths and the estimated level of impact if those recommendations were implemented. Collecting and 
analyzing data on recommendations and their impact level can provide valuable information to public health 
and clinical care decision makers as they design and prioritize strategies to eliminate preventable deaths 
at the local, state, regional and national levels.  
This report is a demonstration of MMRCs’ potential to eliminate preventable maternal deaths and of the 
power of collegial, productive partnerships between stakeholders in maternal mortality prevention at local, 
state, regional and national levels. To further empower stakeholders in this partnership, we next discuss 
emerging issues for MMRCs to consider moving forward: maternal mental health, suicide, substance use 
disorder, severe maternal morbidity, and health equity. 
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Emerging Issues  
Maternal Mental Health Conditions – an Update 
Mental health conditions are one of the leading causes of pregnancy-related death. In addition, while a 
mental health condition (including substance use disorder) may not have caused the death, it may have 
contributed to the death. The association between mental illness and mortality is complicated, because 
mental illness does not directly kill women: it serves as an underlying factor that may result in suicide, 
accidental death, and death due to accidental drug intoxication or homicide.[14-16] 
 
Background 
Assessing mental health conditions as a contributing factor in maternal death. Perinatal mood and anxiety 
disorders are conditions that impact women’s mental health during pregnancy and up to one year after 
delivery. They include depression, anxiety, and affective disorders with psychotic episodes and psychosis. 
Pregnancy and the postpartum period are associated with both the onset of mental illness and relapse.[17] 
Our understanding of maternal mental illness is negatively impacted by the frequency of under-diagnosis 
and misdiagnosis. The result can be inappropriate care, potentially leading to missed opportunities for 
treatment and increased risk of morbidity and mortality. In addition, the metabolic changes of pregnancy 
may require adjustments to adequate pharmacological treatment dosage—especially beginning in the 
second trimester—but many providers are hesitant to treat depression and anxiety with antidepressants in 
pregnancy.[18, 19] Mental illness relapse occurs more frequently when a woman’s dosage of pharmacological 
treatment is decreased in pregnancy, maintained at pre-pregnancy levels, or completely discontinued.[20] 
Providers are challenged because both pharmacotherapy use and non-use carry risks, necessitating a 
potentially complex risk-benefit analysis when considering the treatment of mental health conditions during 
pregnancy and the postpartum period. Adding to this challenge is variability in patient risk tolerance. 
Psychosocial and environmental risk factors associated with maternal mental health conditions 
 Chronic stressors, such as racism and poverty 
 Lack of access to insurance, transportation, and providers 
 Substance use disorder 
 Chronic Disease 
 Obesity 
 Unplanned pregnancy 
 Delay or failure to seek prenatal care 
 Social isolation and lack of social support 
 Childcare-associated stress 
 Homelessness 
 Exposure to violence and trauma 
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Assessing substance use disorder as a contributing factor in maternal deaths. In the U.S., drug overdose 
deaths nearly tripled during 1999-2014. Of all recorded drug overdose deaths in 2014, 60.9% involved an 
opioid. Over time, the majority has been from commonly prescribed opioids, but a recent surge in deaths is 
largely due to heroin and other synthetic opioids.[21] From 2014 to 2015 alone, the death rate from synthetic 
opioids other than methadone increased by 72.2%, and heroin death rates increased by 20.6%. From 2005 
to 2014, the rate of opioid-related inpatient stays increased faster for females than for males: females had 
a higher rate of opioid-related inpatient stays in the majority of U.S. states in 2014.[22] Self-medication with 
substances is associated with increased risk of both suicide and unintentional overdose.[23] Opioid abuse 
and dependence is associated with a 4.6 fold-increased risk of maternal death during hospitalization.[24] 
Treatment for substance use disorder during pregnancy involves a complex assessment of risks related 
not only to pregnancy, but also to interactions with other treatments of comorbid conditions, such as 
antidepressants.  
Psychosocial and environmental factors associated with substance use disorder 
 Mental health conditions 
 Lack of financial resources and insurance 
 Late entry into prenatal care 
 Poor adherence to health care appointments and medical recommendations 
 Poor weight gain during pregnancy 
 Exhibited sedation, intoxication, withdrawal, or erratic behavior 
Assessing maternal suicide. For U.S. women ages 10-44 years, suicide is among the five leading causes 
of death.[25] A recent review suggests that suicidal ideation occurs more often among pregnant women than 
the general population.[26] Among postpartum women, suicide most commonly occurs in the late postpartum 
period (43 to 365 days).[27] 
Psychosocial and environmental risk factors associated with suicide 
 Prior suicide attempt(s) 
 Suicidal ideation 
 Depression during pregnancy or postpartum 
 Substance use disorder 
 Non-adherence with medical recommendations 
 No continuity of care 
 Patient and family lack of knowledge regarding mental health conditions and treatments 
 Postpartum psychosis 
 Previous diagnosis of bipolar disorder 
 Post-traumatic stress disorder 
 Lack of access to insurance, transportation, and providers 
 Intimate partner violence 
 Isolation and lack of social support 
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Using MMRIA 
Data system enhancements  
Mental health conditions are a complicated contributor to maternal mortality that cannot always be detected 
by just the death certificate or the autopsy report. Because of their comprehensive and interdisciplinary 
approach, MMRCs are in a unique position to identify and document the contribution of mental health 
conditions to pregnancy-related mortality.[28, 29] MMRCs have expressed a need for better understanding of 
mental health and substance use issues that influence maternal deaths. In response, MMRIA provides 
definitions of mental health conditions and substance use disorder (Box) and a mental health profile form. 
In addition, MMRIA includes checkboxes in the MMRIA committee decisions form to prompt reflection on 
the influences of mental health conditions and substance use disorder (Figure 15).  
  
Box. Select Definitions Provided in MMRIA. 
 
 
MENTAL HEALTH CONDITIONS 
The woman carried a diagnosis of a psychiatric disorder. This includes postpartum 
depression. 
 
SUBSTANCE USE DISORDER – ALCOHOL, ILLICIT/PRESCRIPTION DRUGS 
Substance use disorder is characterized by recurrent use of alcohol and/or drugs 
causing clinically and functionally significant impairment, such as health problems 
or disability. The committee may determine that substance use disorder 
contributed to the death when the disorder directly compromised a woman’s health 
status (e.g. acute methamphetamine intoxication exacerbated pregnancy-induced 
hypertension, or woman was more vulnerable to infections or medical conditions). 
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Figure 15. Committee Decisions Form, Select Questions and Checkboxes Related to Mental Health Conditions, Substance Use 
Disorder, Suicide, and Homicide. 
 
 
Estimating the contribution of mental health conditions and substance use disorder 
Only MMRCs who entered data into MMRIA (versus its predecessor, MMRDS) were able to use the mental 
health conditions and substance use disorder checkboxes. Thus, we used data from the following forms to 
assess whether mental health conditions or substance use disorder contributed to each pregnancy-related 
death:  
 Death certificate 
 Autopsy report 
 Mental health profile (available in MMRIA only) 
 Social and environmental profile 
 Committee decisions form:  
o Mental health conditions and substance use disorder checkboxes (Figure 15) (available in 
MMRIA only) 
o Determination of contributing factors related to the death 
o PMSS-MM codes 
o Notes about key circumstances surrounding the death 
Specifically, we looked for mentions of mental health conditions, depression, anxiety, bipolar disorder, 
psychosis, or substance use disorder contributing to the death in any way. We then categorized each death 
according to whether a mental health condition or a substance use disorder contributed to the death, and 
whether the death was a suicide.  
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By searching for these keywords in the data from the Nine Committees, we found that mental health 
conditions and substance use disorder contributed to 12.9% and 8.2% of pregnancy-related deaths, 
respectively; 6.5% of pregnancy-related deaths were suicides. In comparison, when looking at PMSS-MM 
codes only, the percentage of pregnancy-related deaths with an underlying cause of death of mental health 
conditions was 7.0%, as shown in Figure 4. This shows that mental health conditions and substance use 
can contribute to deaths even when they are not the underlying cause. As more MMRCs use checkboxes, 
more complete analyses of deaths where mental health conditions or substance use disorder contributed 
to the death, but did not cause the death, will be possible.  
Data from states with the checkboxes available indicated that mental health conditions or substance use 
disorder contributed to just three of the 28 deaths we identified as having mental health conditions or 
substance use disorder. Of the remaining 25 deaths we identified as having mental health conditions or 
substance use disorder, eight had PMSS-MM codes indicating that the underlying cause of death was 
mental health conditions (100.0) or depression (100.1), and two were suicides incorrectly coded as 
intentional injury - homicide (88.1).   
These discrepancies highlight that the use of only one data component currently underestimates the 
contribution of mental health conditions and substance use disorders to pregnancy-related mortality. If 
utilized, the checkboxes in MMRIA can serve as a consistent measure that helps committees better 
understand the contribution of mental health conditions and substance use disorder to maternal mortality. 
Further training to MMRCs on the committee decision form checkboxes and PMSS-MM codes may be 
needed.  
Moving forward 
Documentation of the contribution. Our analyses of the data from the Nine Committees suggest that there 
remains an underascertainment of the contribution of mental health conditions, substance use disorder, 
and suicide to pregnancy-related deaths. We will continue to work with MMRCs to help identify opportunities 
for expanding their scope to include these deaths and to increase use of the checkboxes on the MMRIA 
committee decisions form. 
The National Violent Death Reporting System (NVDRS). The National Violent Death Reporting System is 
a state-based surveillance system covering all types of violent deaths.[30] Forty states, plus Washington, 
D.C. and Puerto Rico, currently participate in the NVDRS. Some MMRCs are already partnering with their 
state violent death reporting system programs to exchange information. We continue to encourage MMRCs 
to work with their NVDRS programs to understand opportunities for improving the identification and 
assessment of pregnancy-related violent deaths. 
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Severe Maternal Morbidity Review 
A maternal death is the most extreme and rarest negative maternal outcome. The small numbers of 
maternal deaths make comprehensive and multidisciplinary review of these deaths feasible, providing an 
efficient way for identifying prevention opportunities that lead to cascading prevention effects on other 
maternal health outcomes (Figure 16). We see this efficiency in the data from the Nine Committees where, 
on average, four contributing factors and three to four recommendations were identified for every one 
pregnancy-related death. Actions taken in response to review committee recommendations can reduce 
negative maternal health outcomes such as severe maternal morbidity (SMM), which are too numerous to 
comprehensively review at a state or even local level. 
Figure 16. Cascading Prevention Impacts and Long-Term Outcomes of Maternal Mortality Review 
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Severe Maternal Morbidity Surveil lance and Facili ty -Based Review 
SMM refers to unexpected outcomes of labor and delivery that result in significant short- or long-term 
consequences to a woman’s health.[31] Nationally, SMM occurs approximately 100 times more commonly 
than a pregnancy-related death.[32] This estimate is based on hospital discharge data and the CDC SMM 
index, currently comprised of 18 SMM indicators (e.g., sepsis, hysterectomy, or shock).[33] The CDC SMM 
index was developed for population-level surveillance purposes but can be confused with SMM review 
processes, which needs to occur within facilities.[34]  
While the CDC SMM index works well for population-level surveillance at the national and state levels,[35-
38] it does not work as well at the facility level.[39] However, it should be acknowledged that even if the index 
worked well at the facility level, the number of SMMs flagged for review would be far too numerous to 
effectively review in the comprehensive way that MMRCs review deaths. For these reasons, two screening 
criteria have been recommended by the American College of Obstetricians and Gynecologists (ACOG) and 
the Society for Maternal Fetal Medicine (SMFM) to trigger review at the facility level for a more limited 
number of cases: transfusion of four or more units of blood and admission of a pregnant or postpartum 
woman to an intensive care unit (ICU).[31] Still, there remains the need for a more specific approach to 
support the efficient identification of SMMs for facility review within those that screen positive from the two 
criteria. These facility reviews can have an important role in identifying facility and health care system-
specific quality improvement opportunities, which can complement the population- and systems-level 
actions generated by MMRCs and Perinatal Quality Collaboratives. 
SMM Review by MMRCs at the State or Local Level  
Many MMRCs have expressed interest in applying their comprehensive case review process to review 
SMMs, but population-level review of all SMM cases would overwhelm any committee. It may be possible 
to triage particular cases for review using the aforementioned guidelines coupled with the following two 
criteria: 1) there is a strong relationship to mortality and 2) the morbidity occurs relatively rarely.  
To understand if any of the SMM index indicators meet these criteria, we examined the 2009-2014 National 
Inpatient Sample. The International Classification of Diseases (ICD-9-CM) diagnosis and procedures codes 
were used to identify pregnancy hospitalizations and hospitalizations with a SMM indicator. We classified 
all pregnancy hospitalizations hierarchically into three periods: prenatal, delivery, and postpartum 
hospitalizations. From the 18 current SMM index indicators, we identified three SMM indicators that are 
present in 95% of in-hospital deaths during pregnancy. These same three SMM indicators were present in 
92% of the deaths that occurred during a prenatal hospitalization, 95% of deaths that occurred during 
delivery hospitalization, and 98% of postpartum in-hospital deaths. While strongly tied to in-hospital deaths, 
the three SMM indicators are a small percentage of the overall SMM index (~8%) and total pregnancy 
hospitalizations (0.1% or approximately 5,500 nationally per year). The three SMM indicators are:  
1. Cardiac arrest/ventricular fibrillation (ICD-9, DX: 427.41, 427.42, 427.5)  
2. Conversion of cardiac rhythm (ICD-9, PR: 99.6x), and 
3. Mechanical ventilation (ICD-9, PR: 93.90, 96.01-96.05 minus 96.04 and 96.7x) 
While these three SMM indicators could potentially be utilized as triggers for state- or local-level SMM 
review by MMRCs, they have not yet been tested for this purpose. 
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Incorporating SMM Information into MMRC Processes 
Rather than reviewing individual SMMs in the comprehensive way that they review deaths, MMRCs may 
be able to increase their ability to identify prevention opportunities more efficiently by incorporating SMM 
information into their processes. Three commonly discussed ways that MMRCs can incorporate SMM 
information include: 
1) Incorporating SMM surveillance information. MMRCs can bring descriptive surveillance information to 
their meetings, providing population-level context for deaths the MMRC reviews. For example, an MMRC 
might review trends, geographic variations, and populations disproportionately affected by the SMM 
indicator Amniotic Fluid Embolism if the MMRC will be reviewing a death caused by Amniotic Fluid 
Embolism. An advantage of SMM surveillance indicators and the SMM index is that they are measured 
using administrative data that are often readily available to MMRC members, and epidemiologists are 
increasingly familiar with using the SMM indicators. Ohio’s Pregnancy-Associated Mortality Review is one 
example of an MMRC that has incorporated SMM surveillance information into development of its 
recommendations. 
2) Incorporating aggregate facility-level review information. As the number of facility-based SMM reviews 
increase within a jurisdiction, this creates opportunities for aggregating SMM information across hospitals 
for use by MMRCs at their meetings. Similar to SMM surveillance information, what is presented to the 
MMRC could be specific to the deaths they will discuss in that meeting, or to the leading causes of 
pregnancy-related death in their jurisdiction. An advantage that facility-based SMM review information has 
over the SMM surveillance data is that the facility review information is potentially richer in details, and is 
from the clinical provider perspective on care received related to SMM. The incorporation of aggregated 
facility-level SMM review information could help with understanding what SMM prevention opportunities 
MMRCs are not able to identify from a review of deaths. There is not currently a MMRC in the United States, 
that we are aware of, which is integrating facility SMM reviews into their processes; however, the New York 
City Maternal Mortality and Morbidity Review Committee (M3RC) is planning to pilot this approach in 2018. 
3) Incorporating SMM survivors’ voices. The voices of women who have survived an SMM can provide 
unique and important information to MMRC discussions which can then broaden recommendations. Two 
approaches for bringing survivors’ voices into reviews are interviewing SMM survivors and including 
survivors as MMRC members. 
4) Interviewing SMM survivors. Interviews with SMM survivors have been conducted across a diversity of 
settings, with recent publications from the United Kingdom [40] to Malaysia.[41] Interviews have taken place 
from one to 10 months after delivery.[40, 42, 43] Evidence suggests that it takes about one month before a 
SMM survivor begins to reflect back on their experience, and so it has been suggested that interviews not 
take place before one month after delivery.[43, 44] There were common findings across these diverse settings. 
Women commonly report fear for their ability to recover and implications for daily activity, frustration at not 
realizing the idealized pregnancy and birth, powerlessness that comes with experiencing the unexpected, 
and trauma from the experience of their emergency and in some cases the loss of a child. In terms of 
implications for care, common themes across these studies include a lack of communication between 
providers and patients (i.e., keeping the woman and her partner informed of what may happen or is 
happening), and a lack of information at discharge on how to manage their health once home. Survivors 
also commonly report lack of communication between emergency care and primary care providers. These 
interviews have typically taken place as part of research studies, rather than as part of ongoing surveillance 
and monitoring processes.  
                                                          
For more information visit:  
ht tps : / /www.odh.oh io .gov/ - /media /ODH/ASSETS/F i les /c fhs /pamr/2017/SMM -Fac t sheet .pdf  
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There is not currently a MMRC in the United States that we are aware of, which has integrated SMM 
interviews into their processes; however, the aforementioned New York City M3RC is planning to pilot this 
approach in 2018. An example of what might come from this approach is provided in Table 5, which 
highlights good quality care practices identified by SMM survivors in the United Kingdom[45].  
 
Table 5. Beneficial care practices identified by SMM survivors in the United Kingdom* 
In the emergency Small personal touches of reassurance by doctors and midwives 
Information and small acts of kindness to reassure partners during anxious waiting 
Transfer in the hospital Sensitivity to women’s emotional and physical needs to ease transfer 
Access to the baby Having access to their baby, even when very ill 
Follow-up Meeting with doctors to understand more about what had happened 
The opportunity to see and go through their notes 
Sensitivity about where follow-up meetings took place 
Communication & 
Understanding 
Good communication with health professionals during pregnancy 
Good communication afterwards to help women make sense of the experience 
Postnatal support Support from their primary care team after discharge, as women recover and try to get back 
to normal life 
Counseling to help with long-lasting mental impacts 
 
*Adapted from Knight M, et al. 2016.[45] 
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5) Including SMM survivors as MMRC members. The inclusion of patient and/or family advisors in clinical 
quality improvement processes is not new, but is new for MMRCs. For a decade, the Joint Commission has 
engaged patients and families through a Patient and Family Advisory Council, recognizing their role in 
helping to address patient safety and health care quality improvement.* The Agency for Healthcare 
Research and Quality has also recognized the value of patient and family engagement in safety and quality 
improvement initiatives in hospitals.[46] State-level safety initiatives have also engaged patient and family 
representatives.[47]  
The Perinatal Quality Collaborative of North Carolina (PQCNC) took a thoughtful approach early in their 
formation to identify what role families should have and how they should be engaged in the perinatal quality 
improvement processes of the PQCNC.[47] The patient and family engagement has evolved over time in the 
PQCNC, from a separate patient and family initiative into integrated representation in their hospitals’ 
Perinatal Quality Improvement Teams.** The success in North Carolina has encouraged and informed the 
engagement of patient and family representatives in other state perinatal quality collaboratives. The Florida 
Perinatal Quality Collaborative (FPQC) has a family representative on their Steering Committee who helps 
to ensure that priority perinatal quality improvement initiatives are informed by the family voice.*** Most 
recently the Illinois Perinatal Quality Collaborative (ILPQC), working in partnership with the Preeclampsia 
Foundation, the March of Dimes, and Hand to Hold, is engaging Patient Advisors to participate on hospital 
teams implementing quality improvement initiatives.**** Currently, we are not aware of any MMRCs that 
include a patient/SMM survivor member. This may reflect the challenge of identifying representatives who 
can provide a holistic voice across the diversity of deaths MMRCs review; nonetheless, including SMM 
survivors as MMRC members may be the most effective ongoing approach for incorporating SMM 
information into MMRC processes. 
 
 
 
  
                                                          
*ht tps : / /www. jo in tcommiss ion.o rg / fac ts_about_ the_pa t ient_and_fam i ly_adviso ry_counc i l /  
** ht tps : / /www.pqcnc .org /  
*** ht tp : / /hea l t h .us f .edu/pub l ichea l th /ch i l es / fpqc  
**** ht tp : / / i l pqc .org /  
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Incorporating Equity – an Update 
Analyt ic Framework: Theoretical Background 
Maternal mortality rates in the United States are higher than many other developed countries, and social 
factors may contribute to this difference.[4] Non-Hispanic black women experience maternal deaths at a rate 
three to four times that of non-Hispanic white women, a racial disparity that is mirrored across many 
maternal and infant outcomes.[4, 48] Studies have suggested that socioeconomic status and geography or 
location are related to maternal death.[2, 49, 50] 
These upstream factors that affect a person’s well-being are sometimes called social determinants of 
health. When conceptualizing the possible relationships between social determinants of health and 
maternal mortality, it is useful to consider the potential pathways. Theoretical models can be used to 
describe and organize social determinants of health and their mechanisms, typically characterized by at 
least three domains: 1) they consider social factors (e.g., socioeconomic status) as multidimensional, 2) 
they situate individuals within multi-level contexts, and 3) they incorporate time in a life course and historical 
framework with respect to the timing and duration of exposures across the life course. Organizing 
determinants into multiple dimensions and levels allows us to consider the context in which a woman lived 
and to understand the potential effects of social factors on her death. 
There is a connection between social determinants of health and location. When women live in areas 
without access to reliable transportation, fresh and affordable groceries, and safe public spaces for 
recreation and fitness, they are more likely to have worse maternal outcomes than women who have access 
to these resources. Many of these social determinants of health are spatially patterned at each level, 
creating geographic variation in risks. For example, rural/urban variation or spatial disparities within urban 
areas may reflect the different contexts of social and health care experiences in each location. If the location 
of health outcomes is known, they can be linked to individual and contextual level variables to describe 
multi-dimensional and multi-level determinants. Considering contextual levels enables us to think directly 
about regional- and systems-level issues and translate findings into specific recommendations at those 
same levels. 
Data Sources 
Geocoding. To be useful in examining maternal mortality or another outcome, community factors need to 
be linked to individual outcomes or events. Many of these contextual variables are publicly available, but 
individual events must have a spatial marker to link them with these variables. Having an address for an 
event allows it to be geocoded, which can then be used to associate it with contextual factors. MMRIA 
collects this information and geocodes each death, allowing MMRCs to incorporate contextual social 
determinants of health into case discussions and examine the relationship between contextual social 
determinants of health and maternal mortality.   
Contextual level variables. Information on the social determinants of health for contextual level variables is 
available from a number of publicly available sources, including the American Community Survey (ACS) 
and the Area Health Resource File (AHRF). The ACS collects demographic and socioeconomic information 
and is sampled on a continuous basis. The AHRF compiles variables on health care access and use from 
multiple sources. 
It is important to consider the spatial level at which variables are measured, because different spatial levels 
correlate with different levels of social determinants. Some variables are measured at the level of census 
tract—a geographic area with 1,200-8,000 residents—which may estimate the influences of a woman’s 
local environment. Other variables are measured at a county level, which approximate a broader set of 
influences, including policies. 
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Limitations. The socio-spatial indicators available can help MMRCs describe contributors to inequity, of 
which geographic, income, and racial-ethnic disparities in pregnancy-related mortality are a symptom. 
However, potentially important indicators are not available. We can describe a community’s access to care 
but not the quality of care provided. We can describe a community’s level of segregation but not its level of 
racism, structural inequity and discrimination, or the chronic stress it causes. We also lack standard 
measures for less tangible but positive influences on maternal health outcomes, such as the presence of 
supportive motherhood groups and other faith- and community-based outreach organizations. We 
prioritized broad domains and illustrative community-based indicators that have previously been associated 
with maternal health and perinatal outcomes such as fetal growth restriction, inadequate or excessive 
maternal perinatal weight gain, pregnancy-related hypertension, or infant mortality. Correlates of these 
perinatal outcomes may also influence risk for maternal death. We can learn from infant mortality and there 
is a lot of momentum to identify better indicators of structural inequity and how they impact maternal 
outcomes.[51-54] As indicators become available, they can be incorporated into the framework. Despite these 
limitations, we present a framework that advances the incorporation of health equity into MMRC 
discussions. 
The MMRIA Equity Framework 
The process of maternal mortality review centers on a comprehensive assessment of the underlying causes 
of each maternal death in order to characterize which deaths are potentially preventable and what 
interventions could be instituted to affect different outcomes in the future. The power in this approach comes 
from the holistic review by multidisciplinary teams that consider the cascade of events leading towards that 
final tragic event.   
The MMRIA tool encourages MMRCs to consider the contributions of patient/family, provider, facility, health 
system and community-level factors as part of the broader context of each death. The presence of large 
and persistent population-level disparities in maternal mortality—by race, class and geography—suggest 
that this”broader context’ for examination should include not only individual-level factors that distinguish 
“high risk” from “low risk” women, but also social contextual factors which systematically expose populations 
of women to higher or lower risk environments. Despite the theoretical importance of looking at socio-spatial 
context and environment as contributors to population disparities in maternal mortality, in our first year 
Report from Maternal Mortality Review Committees: A View into their Critical Role, no committees identified 
“community-level” factors as contributors to pregnancy-related deaths. This could have occurred for one of 
at least three reasons: 
1. There were no deaths for which community factors had a contributing role. 
2. Review committees did not have community-based data on which to base the attribution of 
community-level factors to any cases. 
3. Review committees may not perceive that community-based social determinants of health are 
modifiable, and therefore the death was not preventable at the community level. 
While it is possible that community-based factors had no impact on any deaths, this would counter current 
evidence. While there is very little research testing the role of any specific social determinants of maternal 
mortality, there is substantial evidence supporting the causal role of social determinants for disparities in 
other related morbidity and mortality (e.g., pre-term birth, infant mortality). Therefore, we do not assume 
that the absence of “community-level” factors in our last report is evidence that community-level factors do 
not contribute to pregnancy-related death.  
The social and environmental experiences (e.g., exposures, resources, and opportunities) shared by 
population groups defined by race, class or geography affect individual health behaviors, exposures and 
opportunities. These group-level factors may explain group-level differences in individual risk factor 
prevalence, or, alternatively, the social environment may contribute to the background “usual” rate of 
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disease observed for a given population. To enrich the maternal mortality case narrative with plausible 
community-based contextual data, we developed a framework which builds on four underlying assumptions 
and objectives: 
1. First, we assumed that the geographic communities in which women live, work and seek health 
care contain important opportunities and exposures that pattern women’s health before conception, 
during pregnancy, and postpartum. Thus, geographically-referenced indicators mark potential risks 
related to social determinants of health for mothers.  
2. Second, we identified five broad domains that capture aspects of the health service infrastructure, 
variation in access to quality care, indicators of local population health and the broader 
socioeconomic environment. We identified three health-specific domains (general health 
environment, reproductive health environment, and behavioral health environment), as well as the 
transportation environment, as important community-based determinants of women’s health. We 
further posit that the broader socioeconomic environment influences the density and quality of 
health-specific resources (e.g., the previous four domains), and can also directly affect individual 
health and population health equity.   
3. Third, we sought to identify specific community-based or systems-level indicators or measures that 
rely on existing data and can be readily incorporated into maternal mortality review activities. The 
indicators are selected to capture aspects of the health service environment, the social 
environment, and the state of population health in each woman’s local geographic region. 
4. Finally, we identified evidence-informed policy and programmatic interventions that serve as 
models for the translation of community-level contributors to mortality into future prevention 
activities. We identified the evidence-informed policies using a systematic web-based narrative 
review of the academic literature and publicly available information on existing policy interventions 
addressing the identified community risk factors.  
While the specific indicators continue to evolve, Table 6 lists several illustrative indicators for each domain, 
as well as a brief summary of identified evidence-informed community-based interventions that map onto 
the domains. The summaries are drawn from an inventory of potential policy interventions. Many policies 
are repeated across multiple domains, particularly those addressing disparities in access to specialized 
care in the perinatal period. For example, telemedicine policy interventions—both for direct service 
provision, as well as to increase provider collaboration and training—would be appropriate to address risk 
factors in the general health, reproductive health and behavioral health services environment domains. 
State-administered Medicaid programs have enormous potential to use innovative strategies for improving 
maternal health, reflected here in policy options addressing multiple issues including maternal depression, 
access to interconception care, as well as language and transportation services.  
To integrate these socio-spatial indicators and the table of evidence-informed policies, we propose a visual 
“dashboard” representing the community-based factors for each case with her “community” defined by her 
residential geocoded address. A mock-up of one sample dashboard is represented in Figure 17, with 
interpretation guides in Figure 18. Note that this preliminary dashboard contains only a subset of the 
indicators in Table 6, but a more complete dashboard is in development. In the future, this dashboard will 
be available via the MMRIA system to facilitate the committee’s case narrative development and discussion. 
The “policy menu” will also be provided for facilitating committee recommendations based on their case 
discussions. 
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Table 6. Health Equity Domains, Indicators, and Potential Policy and Programmatic Interventions 
PROPOSED SOCIO-SPATIAL 
INDICATORS DATA SOURCE EXAMPLES OF POSSIBLE INTERVENTIONS FOR THIS DOMAIN 
GENERAL HEALTH SERVICES ENVIRONMENT 
Primary Care provider 
availability 
Area Resource File  Telemedicine (direct service provision and provider continuing 
education) 
 State Medicaid reimbursement policies that incentivize 
telemedicine 
 Training and loan repayment programs to incentivize clinician 
location 
 Mobile health units 
 State administrative and reimbursement policies that incentivize 
providers to accept Medicaid 
Medicaid eligible Area Resource File  
Uninsured SAHIE  
Obesity County 
Rankings/BRFSS 
 
Poor/Fair self-rated health County 
Rankings/BRFSS 
 
REPRODUCTIVE HEALTH SERVICES ENVIRONMENT    
Obstetrician availability Area Resource File  Telemedicine (direct service provision and provider 
collaboration/continuing education) 
 State Medicaid reimbursement policies that incentivize 
telemedicine 
 Collaboration around integration of care and safe transfers 
during birth 
 Mobile health units 
 Family Medicine rotations and residency with a focus on 
obstetric services 
Certified Nurse Midwife 
availability 
Area Resource File Reduce barriers to independent practice for advanced practice 
Registered Nurses 
Family planning needs Guttmacher Institute  State Medicaid patient reimbursement for contraception and 
education in clinical settings 
 Training of primary care physicians on contraceptive methods 
Newborn care resources Area Resource File Integration of care and safe transfer of care 
Infant mortality County 
Rankings/NCHS 
 
Low birthweight County 
Rankings/NCHS 
 
Chlamydia County 
Rankings/CDC 
 
Teen pregnancy County 
Rankings/NCHS 
 
BEHAVIORAL HEALTH ENVIRONMENT    
Mental Health provider 
availability 
Area Resource File  Telemedicine (direct service provision and provider 
collaboration/continuing education) 
 Medicaid reimbursement for maternal depression screening 
during well-child screening 
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PROPOSED SOCIO-SPATIAL 
INDICATORS DATA SOURCE EXAMPLES OF POSSIBLE INTERVENTIONS FOR THIS DOMAIN 
 Provider training on integrating maternal mental health services 
into the clinical setting 
 Increased collaboration between medical and behavioral health 
providers 
Poor mental health days County 
rankings/BRFSS 
 
Frequent mental distress County 
rankings/BRFSS 
 
Drug overdose deaths County rankings/ 
CDC Wonder 
 
Non-medical opioid use SAMHSA/NSDUH  Provision of priority access for maternal drug treatment programs 
 Access to Medication Assisted Treatment for pregnant women 
Any mental illness SAMHSA/NSDUH  
Unmet substance abuse need SAMHSA/NSDUH Public education to reduce stigma among medical professionals 
Prevalence serious thoughts of 
suicide 
SAMHSA/NSDUH  
TRANSPORTATION ENVIRONMENT    
Rural/Urban composition ACS  
Car ownership ACS  State Medicaid reimbursement for non-emergency transportation 
 Public transportation grants and initiatives 
 Ride hailing partnerships 
Long commute driving alone County rankings/ 
ACS 
Ride hailing partnerships 
Public transit availability EPA Smart Location 
Database 
 Public transportation grants and initiatives 
 State Medicaid reimbursement for non-emergency transportation 
 Ride hailing partnerships 
SOCIAL AND ECONOMIC ENVIRONMENT    
Current poverty and persistent 
poverty 
ACS  Increased screening and counseling for intimate partner violence 
 Integrated referrals to social service supports in clinical models 
 Group prenatal care 
Violent Crime FBI Uniform Crime 
Reporting 
Integrated referrals to social service supports in clinical models 
Income Inequality ACS  Increased screening and counseling for intimate partner violence 
 Integrated referrals to social service supports in clinical models 
Educational attainment ACS  Integrated referrals to social service supports in clinical models 
 Group prenatal care 
Severe Housing Problems County rankings  
Ability to speak English ACS  State certification for medical interpreters 
 Medicaid reimbursement for language services 
 Video medical interpretation 
Racial & Economic  Segregation ACS  
 
Report from Nine Maternal Mortality Review Committees 51 
  
F
ig
u
re
 1
7
. 
In
te
rp
re
ti
n
g
 t
h
e
 (
P
ro
p
o
s
e
d
) 
M
M
R
IA
 S
o
c
io
-S
p
a
ti
a
l 
D
a
s
h
b
o
a
rd
 
Report from Nine Maternal Mortality Review Committees 52 
 
 
 
 
  
F
ig
u
re
 1
8
. 
E
x
a
m
p
le
 o
f 
M
M
R
IA
 S
o
c
io
-S
p
a
ti
a
l 
D
a
s
h
b
o
a
rd
 
Report from Nine Maternal Mortality Review Committees 53 
 
 
 
 
Moving forward  
Contextual level measures. We have developed a theoretical basis for examining social determinants at a 
contextual level for maternal mortality and have identified a preliminary set of contextual measures related 
to maternal mortality.   
Understanding the relationship between equity and maternal mortality. We will continue to refine the analytic 
approaches for examining the association of selected socio-spatial variables with maternal mortality. A 
priority is to explore and document the implications for using different potential measures to represent 
maternal mortality, considering the rate (per woman of reproductive age) and the ratio (per live births). 
Effective analyses of the association between the exposure of contextual-level social determinants and the 
outcome of pregnancy-associated mortality can then be conducted. 
Incorporating equity into review discussions. We will work closely with MMRCs, supporting their 
incorporation of this information into case narrative development and committee discussions and decisions. 
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Summary 
The process of maternal mortality review centers on a comprehensive assessment of the underlying causes 
of each maternal death in order to characterize which deaths are potentially preventable and what 
interventions could be instituted to affect different outcomes in the future. MMRCs have made significant 
progress towards using a common set of data elements to comprehensively assess and address maternal 
deaths. We are gaining insight into not only the underlying causes of death, but to the cascade of events 
ultimately leading to the tragic event. With this powerful insight, MMRCs are targeting recommendations for 
action. As more data are available, further analyses within and across race-ethnicity, age at death, cause 
of death, and geography will be possible. Improved richness of recommendation descriptions will also 
deepen our understanding of the best opportunities for preventing pregnancy-related deaths.   
Mental health conditions continue to be a leading underlying cause of pregnancy-related maternal deaths, 
and they serve as contributors to even more maternal deaths. MMRCs are in a unique position to identify 
and document the contribution of mental health conditions to pregnancy-related mortality because of their 
comprehensive and multidisciplinary approach. We will continue to work with MMRCs to identify 
opportunities and tools to assist in the review and documentation of deaths related to mental health 
conditions and substance use disorder.  
A maternal death is the most extreme and the most rare negative maternal outcome. Actions taken in 
response to review committee recommendations can lead to reductions in negative maternal health 
outcomes that may be too common to individually review at a state or local level (e.g., severe maternal 
morbidity). Lastly, social and environmental factors may contribute to a woman’s risk of dying during or 
within one year of pregnancy. MMRCs can incorporate contextual social determinants of health into case 
discussions, and translate findings into specific recommendations at the regional- and systems-level.  
Each maternal death is one too many. While we encourage existing MMRCs to comprehensively review 
cases, we will continue technical assistance on establishing MMRCs and MMRIA system development to 
address emerging issues. The Building U.S. Capacity to Review and Prevent Maternal Deaths team will 
also work on an updated 2019 Report from Maternal Mortality Review Committees to release early next 
year.  
State- and local-level MMRCs are poised to be the gold standard for understanding why maternal deaths 
continue to occur and make recommendations for action. However, there is still more work to do to connect 
MMRC data to action. Commitment at multiple levels is necessary to achieve this goal. Women and families 
deserve no less.  
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Appendix A: 
Maternal Mortality Review Committee Decisions Form 
Form begins on the next page. 
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Appendix B:  
Underlying Cause of Death Regroupings 
REGROUPING SPECIFIED CAUSES INCLUDED IN REGROUPING  
Accidental Overdose  
Anesthesia Complications  
Amniotic Fluid Embolism  
Autoimmune Diseases Systemic lupus erythematosus, Other collagen vascular diseases/Not otherwise specified 
Blood Disorders Sickle cell anemia, Other hematologic conditions including thrombophilias/Thrombotic 
thrombocytopenic purpura/Hemolytic uremic syndrome/Not otherwise specified 
Cardiomyopathy Postpartum/peripartum cardiomyopathy, Hypertrophic cardiomyopathy, Other cardiomyopathy/Not 
otherwise specified 
Cardiovascular and Coronary 
Conditions  
Coronary artery disease/Myocardial infarction/Atherosclerotic cardiovascular disease, Pulmonary 
hypertension, Valvular heart disease, Vascular aneurysm/Dissection, Hypertensive cardiovascular 
disease, Marfan’s syndrome, Conduction defects/Arrhythmias, Vascular malformations outside the 
head and coronary arteries, Other cardiovascular disease, including congestive heart failure, 
cardiomegaly, cardiac hypertrophy, cardiac fibrosis, and non-acute myocarditis/Not otherwise 
specified 
Cerebrovascular Accidents Hemorrhage/thrombosis/aneurysm/ malformation, but not secondary to hypertensive disease 
Conditions Unique to Pregnancy e.g., Gestational diabetes, Hyperemesis, Liver disease of pregnancy 
Embolism Thrombotic (non-cerebral), Amniotic fluid, Other embolism/Not otherwise specified 
Hemorrhage Rupture/Laceration/Intra-abdominal bleeding; Placental abruption, Placenta previa, Ruptured ectopic 
pregnancy, uterine atony/ postpartum hemorrhage, Placenta accreta/increta/percreta, due to 
retained placenta, due to primary disseminated intravascular coagulation, Other hemorrhage/not 
otherwise specified 
Homicide Intentional injury  
Infection Postpartum genital tract (e.g., of the uterus/pelvis/perineum/necrotizing fasciitis), Sepsis/septic 
shock, Chorioamnionitis/antepartum infection, Non-pelvic infections (e.g., pneumonia, H1N1, 
meningitis, HIV), Urinary tract infection, Other infections/Not otherwise specified 
Liver and Gastrointestinal 
Conditions 
Crohn’s disease/Ulcerative colitis, Liver disease/failure/transplant, Other gastrointestinal 
diseases/Not otherwise specified 
Malignancies Gestational trophoblastic disease, Malignant melanoma, Other malignancies/Not otherwise specified 
Mental Health Conditions Depression, Other psychiatric conditions, Suicide 
Metabolic / Endocrine Conditions Obesity, Diabetes mellitus, Other metabolic/Endocrine disorders/Not otherwise specified 
Preeclampsia and Eclampsia  
Pulmonary Conditions (Excluding 
Adult Respiratory Distress 
Syndrome) 
Chronic lung disease, Cystic fibrosis, Asthma, Other pulmonary disease/Not otherwise specified 
Renal Diseases  
Seizure Disorders Epilepsy/seizure disorder, Other neurologic diseases/Not otherwise specified 
Unintentional Injury e.g., Motor vehicle accidents, Accidental overdose, Smoke inhalation, Drowning 
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Appendix C:  
Contributing Factors by Leading Causes of Death 
Cardiovascular and Coronary Conditions 
FACTOR LEVEL 
(% OF TOTAL 
FACTORS) 
MOST COMMON FACTOR 
CLASS(ES) 
(% OF LEVEL-SPECIFIC 
CLASSES) COMMON THEMES 
Facility Access/Financial  
(10.0%) (20.0%)  
 Continuity of Care/Care 
Coordination 
Lack of coordination between providers that supports 
coordinated care 
 (20.0%)  
Patient/Family Chronic Disease  Obesity 
(42.5%) (25.5%)  
 Knowledge Lack of knowledge on warning signs and need to seek care 
 (15.7%)  
 Substance Use Disorder Substance Use 
 (13.7%)  
 Adherence Lack of adherence to medications or treatment plan 
 (11.8%)  
Provider Knowledge Delayed diagnosis or treatment 
(21.7%) (16.7%) Ineffective treatments 
 Communication Failure to seek consultation 
 (12.5%) Lack of communication with patient and/or other providers 
 Continuity of Care/Care 
Coordination 
Lack of coordination between providers that supports 
continuity of care 
 (12.5%)  
Systems of Care Communication Lack of communication between providers that supports 
coordinated care 
(20.8%) (21.7%) Inadequate or unavailable personnel 
Community   
(5.0%)     
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Hemorrhage  
FACTOR LEVEL 
(% OF TOTAL 
FACTORS) 
MOST COMMON FACTOR 
CLASS(ES) 
(% OF LEVEL-SPECIFIC 
CLASSES) COMMON THEMES 
Facility Clinical Skill/Quality of Care  
(7.0%) (33.3%)  
 Policies/Procedures  
 (33.3%)  
Patient/Family Knowledge Lack of knowledge on warning signs and need to seek care 
(26.0%) (30.8%)  
 Cultural/Religious  
 (15.4%)  
Provider Assessment Delayed or missed diagnosis or treatment 
(31.0%) (33.3%) Ineffective treatments 
 Knowledge Failure to seek consultation 
 (13.3%)  
Systems of Care Personnel Inadequate training 
(36.0%) (27.8%) Inadequate or unavailable personnel 
 Policies/Procedures Lack of applicable policies and procedures 
 (19.4%)  
 Continuity of Care/Care 
Coordination 
Lack of coordination and communication between providers that 
supports patient management 
 (16.7%)  
Community   
(0%)     
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Cardiomyopathy  
FACTOR LEVEL 
(% OF TOTAL FACTORS) 
MOST COMMON FACTOR CLASS(ES) 
(% OF LEVEL-SPECIFIC CLASSES) COMMON THEMES 
Facility   
(1.7%)   
Patient/Family Chronic Disease Obesity 
(43.1%) (25.8%) Unaware of warning signs and need to seek care 
 Adherence Lack of adherence to medications or treatment plans 
 (12.9%)  
 Substance Use Disorder Substance use 
 (12.9%)  
Provider Assessment Failure to screen 
(41.4%) (33.3%) Delayed or missed diagnosis or treatment 
 Knowledge Misdiagnosis or ineffective treatments 
 (16.7%)  
 Referral Failure to seek consultation 
 (16.7%)  
Systems of Care Personnel Inadequate training 
(13.8%) (27.3%) Inadequate or unavailable personnel 
Community   
(0%)     
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Infection  
FACTOR LEVEL 
(% OF TOTAL 
FACTORS) 
MOST COMMON FACTOR 
CLASS(ES) 
(% OF LEVEL-SPECIFIC 
CLASSES) COMMON THEMES 
Facility   
(1.1%)   
Patient/Family Chronic Disease Obesity and other contributing diagnoses 
(34.1%) (30.0%)  
 Environmental Housing and other contributing factors 
 (16.7%)  
 Knowledge Lack of knowledge on warning signs and need to seek care 
 (13.3%)  
 Substance Use Disorder Substance use 
 (13.3%)  
Provider Assessment Delayed or missed diagnosis or treatment 
(40.9%) (41.7%) Ineffective treatments 
 Knowledge Misdiagnosis 
 (11.1%)  
Systems of Care Communication Lack of communication between providers that supports 
coordinated care 
(22.7%) (20.0%)  
 Personnel Inadequate training 
 (15.0%)  
Community   
(1.1%)     
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Embolism  
FACTOR LEVEL 
(% OF TOTAL 
FACTORS) 
MOST COMMON FACTOR 
CLASS(ES) 
(% OF LEVEL-SPECIFIC 
CLASSES) COMMON THEMES 
Facility   
(0%)   
Patient/Family Chronic Disease Obesity and other contributing diagnoses 
(65.2%) (53.3%)  
 Knowledge Lack of knowledge on warning signs and need to seek care 
 (20.0%)  
 Substance Use Disorder Substance use 
 (13.3%)  
Provider Knowledge Lack of knowledge about the use of anticoagulants and 
thrombolytics 
(21.7%) (60.0%)  
Systems of Care   
(13.0 %)   
Community   
(0%)     
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Mental Health*  
FACTOR LEVEL 
(% OF TOTAL 
FACTORS) 
MOST COMMON FACTOR 
CLASS(ES) 
(% OF LEVEL-SPECIFIC 
CLASSES) COMMON THEMES 
Facility Split across multiple classes Inadequate assessment of risk 
(3.4%)   
Patient/Family 
(42.1%) 
Split across multiple classes Lack of adherence to medications or treatment plans 
Abusive relationships and unstable housing 
Substance use 
Lack of social support systems 
Lack of knowledge on warning signs and need to seek care 
Provider Assessment Failure to screen 
(27.3%) (25.0%) Ineffective treatment 
Inadequate assessment of risk leading to delayed diagnosis, 
treatment, or follow-up 
 Communication Lack of communication between providers to support coordinated 
care 
 (20.1%) Lack of communication or ineffective communication between 
providers and patients/families 
 Continuity of Care/Care 
Coordination 
Lack of follow-up by provider 
 (12.5%) Failure to seek consultation 
Systems of Care Communication Lack of communication between providers that supports patient 
management 
(21.6%) (22.2%)  
 Continuity of Care/Care 
Coordination 
Inadequate outreach support system 
 (22.2%) Inadequate or unavailable personnel 
Community   
(5.7%)     
 
*Themes identified among deaths where mental health was determined to be a contributing factor (n=38) 
were also included. 
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Preeclampsia and Eclampsia  
FACTOR LEVEL 
(% OF TOTAL 
FACTORS) 
MOST COMMON FACTOR 
CLASS(ES) 
(% OF LEVEL-SPECIFIC 
CLASSES) COMMON THEMES 
Facility  Inappropriate level of care 
(3.6%)   
Patient/Family Chronic Disease Substance use 
(23.2%) (30.1%) Obesity 
 Knowledge Lack of knowledge on warning signs and need to seek care 
 (15.4%)  
Provider Knowledge Delayed diagnosis or treatment 
(51.8%) (20.7%) Misdiagnosis or ineffective treatment 
 Referral Failure to seek consultation 
 (13.8%)  
 Assessment Failure to screen 
 (10.3%)  
 Clinical Skill/Quality of Care  
 (10.3%)  
Systems of Care Communication Lack of communication between providers that supports patient 
management 
(17.9%) (40.0%)  
Community   
(3.6%)     
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Appendix D: 
Recommendations for Action with Select Examples 
IMPROVE TRAINING 
Training on safe methods and medication during labor induction, including appropriate use of vacuum and forceps during delivery 
Provider education on how to perform cardiac exams 
Training on caring for patients with drug addiction 
Death certificate training for clinicians 
Training for emergency room staff on the care of pregnant women 
Provider education on patient follow-up 
Training on how to administer mental health and suicide assessments and steps to take following positive results 
ENFORCE POLICIES AND PROCEDURES 
Enforce policies related to obstetric hemorrhage 
ADOPT MATERNAL LEVELS OF CARE/ENSURE APPROPRIATE LEVEL OF CARE DETERMINATION 
Establish levels of care to properly triage patients 
Address resource requirements in level three and four hospitals 
Establish a regional system for perinatal emergent care 
Adopt maternal levels of care 
IMPROVE ACCESS TO CARE 
Improve access to prenatal care services 
Improve access to care for Medicaid patients with chronic conditions 
Improve access to medical translator services 
IMPROVE PATIENT/PROVIDER COMMUNICATION 
Improve provider counseling on delivery options and potential risks 
IMPROVE PATIENT MANAGEMENT FOR MENTAL HEALTH CONDITIONS 
Improve documentation in medical records on mental health 
Provide immediate referrals for counseling and mental health treatment 
Provide referrals to suicide prevention programs and domestic violence programs if needed 
IMPROVE PROCEDURES RELATED TO COMMUNICATION AND COORDINATION BETWEEN PROVIDERS 
Determine who will care for specific high-risk obstetric patients and the expertise required for each procedure 
Identify quality improvement procedures and implement periodic drills, including obstetric emergency drills for birthing hospitals 
Improve hand-off communication 
Improve communication with emergency room staff 
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IMPROVE PROCEDURES RELATED TO COMMUNICATION AND COORDINATION BETWEEN PROVIDERS 
Improve documentation of abnormal test results and management plan 
Improve assessment and documentation of risk factors during prenatal visits 
IMPROVE STANDARDS REGARDING ASSESSMENT, DIAGNOSIS AND TREATMENT DECISIONS 
Improve standards regarding admission to critical care ICU 
Obtain cardiovascular consults for morbidly obese patients 
IMPROVE POLICIES RELATED TO PATIENT MANAGEMENT, COMMUNICATION AND COORDINATION BETWEEN 
PROVIDERS, AND LANGUAGE TRANSLATION 
Use home health agencies 
Improve policies on follow-up and care coordination of high-risk patients, or patients with mental health conditions or substance 
use disorder 
IMPROVE POLICIES REGARDING PREVENTION INITIATIVES, INCLUDING SCREENING PROCEDURES AND 
SUBSTANCE USE PREVENTION OR TREATMENT PROGRAMS 
Improve policies on risk factor assessment and counseling prior to hospital discharge 
Enroll smokers in smoking cessation programs 
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